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Abstract 
Variation in rapid sequence induction and intubation (RSII): a survey 
on current practice in the Department of Anaesthesiology at the 
University of the Witwatersrand (Wits) 
Background:   Aspiration remains one of the major, preventable complications of 
general anaesthesia.  Controversy regarding various aspects of RSII exists and there are 
no South African guidelines.   The aim of this study was to describe the current practice 
of RSII by anaesthetists in the Department of Anaesthesiology at the University of the 
Witwatersrand. 
Method: A prospective, contextual, descriptive study was done.  Questionnaires 
consisting of seven vignettes were distributed to survey current clinical practice.  A 
60.1% response rate was achieved. 
Results: There was considerable deviation from the original technique of RSII, with 
regard to induction agents, timing of NMBA administration and opioid use prior to 
induction. The induction agent and neuromuscular blocking agent (NMBA) of choice 
was propofol and succinylcholine. Succinylcholine was used for 83 (67.5%) of 
appendicectomies, 118 (96.7%) of Caesarean sections and 83 (68.0%) for bowel 
obstructions.  Alternative NMBA were used for the other scenarios. The majority of the 
respondents, 97 (77.6%), considered the use of a NMBA other than succinylcholine to 
describe a modified RSII.  No statistically significant variation in technique between 
senior and junior anaesthetists was evident, with the exception of the NMBA used for 
appendicectomies (p= 0.0017) and neonates (p=0.0297).   
 
Conclusion: Despite little variation in technique of RSII between consultant and trainee 
anaesthetists at Wits, their current practice shows marked variation from the technique 
originally described.  This change in practice may be the result of advancement in 
knowledge, equipment, technique and available drugs.  Furthermore, it is in keeping 
with international practice.     
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Chapter 1 
1.0 Overview of the study 
1.1 Introduction 
This chapter on rapid sequence induction and intubation (RSII) will address the 
background, problem statement, aim, objectives of this study as well as the research 
assumptions.  It will discuss the study population, location of the study and the research 
methods used.  It will further discuss the ethical considerations whilst performing the 
study.  Finally it will provide an overview of the study and its significance.  
 
1.2 Background 
Anaesthesiologists are responsible for the safe management of the airway during a 
procedure (1).  It has been suggested that as a community the most important focus of 
anaesthetic education should be on the reduction in both the frequency and severity of 
airway complications (2).  
Aspiration remains one of the major, preventable complications of general anaesthesia 
(1, 3, 4).  The first case of anaesthetic aspiration-associated pneumonia was described 
by Simpson in 1848 (5).  Currently, the incidence of aspiration during general 
anaesthesia varies according to different studies (6, 7), but is quoted to be between one 
in 2000 to 3000 for adults (1, 8) and accounts for nearly 50% of reported serious 
incidents, including death (1). Aspiration occurs most commonly: 
 during emergency procedures; 
 as a result of inadequate anaesthesia (8); and 
 due to failure to identify and alter the anaesthetic technique when aspiration is a 
risk despite generally accepted risk factors (1, 8). 
The consequences of aspiration and regurgitation are well recognised and include 
prolonged intensive care admission, aspiration pneumonia, hypoxic brain damage and 
death amongst others (3). 
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Sellick (9), one of the pioneers of cricoid pressure (CP) described the Sellick manoeuvre 
in 1961.  It was the method by which the oesophagus could be compressed during a 
rapid sequence induction to prevent the aspiration of gastric contents.  It later became 
one of the cornerstones of RSII as well as one of the most controversial practices in 
today’s practice (9).  Subsequently, in 1970 Stept et al. (10) published an article 
describing the classical method of RSII, which was initially adopted by anaesthetists 
worldwide.  The method they proposed involved oxygen administration, rapid injection 
of a predetermined dose of thiopental immediately followed by succinylcholine, 
application of CP, and avoidance of positive pressure ventilation before tracheal 
intubation with a cuffed endotracheal tube (10).  
 
Recent surveys have shown a movement away from this technique as the drugs, 
knowledge and equipment have evolved (11-16).  This has resulted in increased 
treatment variation, particularly through the use of neuromuscular blocking agents 
(NMBA) as well as the practices adopted when performing a RSII.  The variation is 
largely determined by the patient presented to the practitioner at the time of surgery.  
Furthermore, there seems to be some distinction between methods and drugs adopted 
by more experienced practitioners compared to those still in training (11, 12). There is 
no clear consensus in the literature with regard to the definitions of the various 
practices or the techniques that should be used to achieve rapid induction and 
intubation of patients at risk of aspiration (14).  What is striking is the continued 
morbidity and mortality resulting from aspiration during anaesthesia despite on-going 
developments in drugs, airway devices and anaesthetic techniques (3). 
 
International guidelines on preventing anaesthetic associated aspiration focus on the 
different aspects of aspiration prevention and management that are extensively debated 
within the literature (1, 17).  Of note, is the failure to reach consensus on the application 
of CP, positive pressure ventilation, placement of a nasogastric tube (NGT) and patient 
positioning during performance of a RSII (1, 17).  This is in part the result of varying 
beliefs and concerns with regard to the varying techniques when performing a RSII.  
Failure to identify appropriate guidelines and reach a consensus on these issues, 
continues to contribute to the on-going morbidity and mortality of anaesthetic related 
aspiration (18). 
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A review of the national literature has not identified any studies focusing on the current 
practice of practitioners.  Furthermore, it yielded no national guidelines pertaining to 
the practice of RSII. 
 
1.3 Problem statement 
Internationally there is controversy regarding the technique of a RSII including the use 
of CP, positive pressure ventilation, patient positioning, placement of a NGT and the 
drugs used during the RSII.  Failure to reach consensus on the technique to achieve 
rapid intubation in the face of aspiration, has resulted in further reports of patients 
aspirating. (18) 
With the introduction of additional anaesthetic agents the potential for modification of 
the original RSII has developed.  Thus a modified approach may be adopted in certain 
clinical situations to achieve improved outcomes and a reduction in risk exposure.  
Failure to provide standardisation of the techniques to be adopted in patients at risk of 
aspiration has resulted in a variety of techniques being applied to different clinical 
scenarios.   There is further discrepancy in the management of these patients, between 
experienced practitioners and trainees (11). 
No guidelines have been identified for the performance of a RSII, on patients at risk of 
aspiration, in the South African literature.   Despite the low incidence of aspiration as 
quoted in the international literature, the high morbidity and mortality associated with 
aspiration is a cause for concern (2, 4, 6, 8).  Furthermore, there is no literature on the 
current clinical practice with regard to RSII in the Department of Anaesthesiology at the 
University of the Witwatersrand (Wits). 
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1.4 Aim and objectives 
1.4.1 Aim 
The aim of this study was to describe the current practice of anaesthetists in the 
Department of Anaesthesiology at Wits when performing a RSII using seven clinical 
vignettes. 
1.4.2 Objectives 
The primary objectives of this study were to: 
 determine the proportion of anaesthetists who recognise patients at risk of 
pulmonary aspiration; 
 describe the choice of induction agent used for a RSII; 
 describe the choice of NMBA used for a RSII; 
 describe the technique used when performing a RSII. 
The secondary objectives of this study were to: 
 compare the difference in technique between the consultant and trainee 
anaesthetists; 
 compare the difference in induction agents between the consultant and trainee 
anaesthetists; 
 compare the difference in NMBA between the consultant and trainee 
anaesthetists; 
 describe the anaesthetists definition of a modified RSII. 
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1.5 Research assumptions 
The following definitions were used in this study. 
Rapid sequence induction and 
intubation (RSII) 
The practice of inducing anaesthesia and 
intubating a patient using preoxygenation, a 
predetermined dose of an induction agent, 
cricoid pressure, succinylcholine and a cuffed 
endotracheal tube with the absence of bag mask 
ventilation.  For the purpose of this study a RSII 
will be considered to have been performed when 
both a cuffed endotracheal tube and CP are used.  
When considering the technique of a RSII the 
induction agent and NMBA used as well as the 
method and timing of administration will be 
considered.  Furthermore, the use of adjuncts 
including opioids, benzodiazepines, insertion of a 
NGT and bag mask ventilation will be analysed.  
 
Modified rapid sequence 
induction and intubation 
Any change in practice from the originally 
described technique of performing a rapid 
sequence induction and intubation including 
titration of an induction agent, exclusion of 
cricoid pressure, an alternative neuromuscular 
blocking agent and bag mask ventilation. 
 
Anaesthetist Any qualified doctor currently working in the 
Department of Anaesthesiology including 
registrars, medical officers, interns and specialist 
consultants. 
 
Consultant A doctor who has completed and obtained their 
specialisation from the Colleges of Medicine in 
South Africa or an international equivalent and is 
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registered with the Health Professional Council of 
South Africa.   
 
Registrar A qualified doctor who is registered with the 
HPCSA as a trainee anaesthetist in the speciality 
of anaesthesiology. 
 
Medical Officer A qualified doctor practising in the Department 
of Anaesthesiology under specialist supervision.     
 
Intern A doctor who has completed a university degree 
but is currently undergoing practical training 
prior to registration with the HPCSA as an 
independent practitioner. 
 
Trainees All respondents (including registrars, medical 
officers and interns) other than consultants. 
 
1.6 Demarcation of study 
The study was conducted in the Department of Anaesthesiology affiliated to the 
University of the Witwatersrand.  This included anaesthetists practicing at the Charlotte 
Maxeke Johannesburg Academic Hospital, Chris Hani Baragwanath  Academic Hospital, 
Rahima Moosa Mother and Child Hospital and Helen Joseph Hospital. 
 
1.7 Ethical considerations 
Approval to conduct this study was obtained from relevant authorities.  Consent was 
implied upon completion of the anonymous self-administered questionnaire. The study 
was conducted adhering to good clinical research practice in accordance with the South 
African Good Practice Guidelines (19) and the Declaration of Helsinki (20).  
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1.8 Research methodology 
1.8.1 Study design 
The research design used in this study was a prospective, contextual, descriptive design.  
1.8.2 Study population 
The study population included anaesthetists in the Department of Anaesthesiology at 
Wits. 
1.8.3 Study sample 
The sample size was determined in consultation with a biostatistician.  Sampling was 
done using a convenience sampling method. 
1.8.4 Inclusion and exclusion criteria 
All the anaesthetists in the Department of Anaesthesiology were invited to participate in 
the study.  Inclusion and exclusion criteria were defined. 
1.8.5 Data collection 
Data collection instrument and method 
A questionnaire including seven vignettes based on the Questionnaire used in the Wales 
study(11), was used to survey current clinical practice.  During the study period 
questionnaires were handed out during the various departmental meetings to the 
anaesthetists in the Department of Anaesthesiology.    
1.8.6 Data analysis 
A Microsoft ExcelTM spreadsheet was used to capture all recorded data.  The data was 
analysed in conjunction with a biostatistician using Microsoft ExcelTM and GraphPad 
InStatTM.  Descriptive and inferential statistics were used. 
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1.9 Significance of the study 
Aspiration remains one of the leading causes of anaesthetic-related morbidity and 
mortality (2).  Despite the low incidence of aspiration, it is a genuine concern for the 
anaesthetist.  In the Fourth National Audit Project of the Royal College of Anaesthetists 
it was found that aspiration was the most common cause of anaesthetic-related deaths 
reported, accounting for up to 50% of all anaesthetic related deaths. (2) 
The technique of RSII used for a patient recognised to be at risk of aspiration will be 
influenced by the patient comorbidities.  In addition, the development of new 
techniques, drugs and equipment has resulted in a wide variation in the practice of a 
RSII. (3, 11-14)  This variation, in practice, may account for the ongoing occurrence of 
aspiration.   
The results of this survey have helped to identify the different practices regarding the 
RSII in the Department of Anaesthesiology at Wits.  Moreover, it has allowed an 
assessment of whether the appropriate practice is being applied to the appropriate 
patient.   This may influence not only academic teaching, but may serve to improve 
patient safety. 
 
1.10 Validity and reliability 
Measures were taken to ensure the validity and reliability of the study. 
 
1.11 Overview 
The chapters in this study include: 
Chapter 1: Overview of the study 
Chapter 2: Literature review 
Chapter 3: Research methodology 
Chapter 4: Results and discussion 
Chapter 5: Summary, limitations, recommendation and conclusion 
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1.12 Summary 
In this chapter, an overview of the study has been given.  The literature review is 
presented in the following chapter. 
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Chapter 2 
2.0       Literature review 
2.1       Introduction 
“There is one skill above all else that an anaesthetist is expected to exhibit and that is to 
maintain the airway impeccably”(21) M Rossen and IP Latto 1984.   
Since 1946, the risk of aspiration as described by Mendelson, has been a concern 
following induction of anaesthesia in “at risk patients” (22).  It was Stept et al. (10) in 
1970, who developed a set of guidelines to achieve rapid sequence induction and 
intubation in these patients (10).  However, despite the worldwide acceptance of this 
technique, the on-going development of drugs and equipment has resulted in some 
adaptation of this originally described technique (3, 11, 13, 14).  Moreover, the 
continued occurrence of aspiration and the problem it poses to the anaesthetist, in 
addition to the potential for adverse sequelae, has resulted in further investigation 
regarding the technique. 
 
2.2       Aspiration 
Aspiration is described as a witnessed regurgitation or aspiration of gastric contents 
often associated with coughing or choking.  It may be witnessed or suspected based on 
radiological findings (4, 8).  Pulmonary aspiration results in three clinically described 
scenarios. 
 
 Aspiration of particulate matter results in airway obstruction causing either 
lobar collapse or complete obstruction and suffocation.  Patients present with 
cyanosis, tachypnoea, and consolidation. 
 Acid aspiration presents in two phases.  In the primary phase, chemical burns to 
the airways occurs within five seconds of the aspiration.  At six hours there is 
evidence of cilia and type II pneumocyte destruction.  There is further increase in 
blood-gas interface permeability with alveolar and pulmonary oedema.  The 
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second phase, is associated with an inflammatory response resulting in acute 
lung injury, acute respiratory distress syndrome and death. 
 Superimposed bacterial infection is often associated with pneumonia and a 
preponderance to abscess formation and cavitation. (3) 
              
Although the incidence of aspiration as quoted in the literature is as infrequent as one 
per 2000 to 3000 in adults (6, 8, 23), it still remains a leading cause of airway associated 
morbidity contributing to up to 50% of complaints and airway associated deaths (24, 
25).  It is recognised that the risk of aspiration occurs more commonly after hours, with 
emergency procedures, obstetric patients and extremes of age (3, 6, 23).  There is 
furthermore, a correlation between the American Society of Anaesthesiology (ASA) 
physical status and risk of aspiration.  There is a recognised increase in morbidity and 
mortality associated with the patient’s ASA status(26).  The generally accepted risk 
factors for aspiration include: 
 
 incompetence of the lower oesophageal sphincter (LOS) (hiatus hernia, gastro-
oesophageal reflux, oesophageal disease); 
 increased gastric volumes (gastric outlet obstruction, bowel obstruction, ileus, 
use of opioids, pneumoperitoneum secondary to laparoscopy); 
 obesity; 
 pregnancy; 
 patient position (lithotomy, Trendelenburg); 
 inadequate anaesthesia; 
 neurological deficit including inadequate reversal of neuromuscular blockade. 
(3, 24, 27) 
The risk of aspiration in “at risk patients” exists throughout the anaesthetic.  It occurs 
most commonly at the time of induction.  However, risk can continue throughout 
maintenance and extubation where incidences of aspiration have been described. (25) 
 
Although debate exists as to the efficacy with which a RSII reduces the incidence of 
aspiration, it is still widely adopted for patients identified as being “at risk”(26).  The 
problem arises where there is a patient contraindication to various elements of the 
technique.  The RSII as described with the use of propofol and thiopentone in 
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predetermined doses is considered to be a relatively haemodynamically unstable form 
of induction (18, 28).  Furthermore, the multiple contraindications to succinylcholine 
limit its use in a large subset of patients.  However, this has largely been superseded 
with the use of rocuronium and other NMBAs via various techniques. (29) 
 
2.3 Technique 
RSII is a technique designed to facilitate rapid intubation of “at risk patients” whilst 
minimising the duration between induction and placement of a cuffed endotracheal 
tube (18).  The originally described method included 15 steps.  
 
 “Establishment of an intravenous infusion. 
 Equipment check including tracheal tube, cuff and stylet. 
 Insertion of a large-bore NGT and application of intermittent strong suction to 
decompress the stomach. 
 Removal of foreign material from the mouth and pharynx. 
 Preoxygenation of the lungs for at least two minutes. 
 Positioning the patient in a semi sitting, V-position, to counteract gravity. 
 The use of an ECG or precordial stethoscope to monitor the heart. 
 Initiation of sequence with the administration of 3mg/70kg of d-tubocurarine. 
 Administration of a predetermined does of thiopental (the recommended dose of 
150mg/70kg). 
 The application of CP following loss of consciousness. 
 Administration of succinylcholine at a dose of 100mg/70kg immediately 
following the dose of thiopental or loss of consciousness. 
 Apnoea and full neuromuscular blockade as determined by a nerve stimulator. 
 Removal of mask whilst maintaining CP to intubate the trachea rapidly (the 
absence of bag mask ventilation prior to intubation). 
 Once tracheal intubation is achieved the endotracheal tube cuff is inflated, CP is 
released and ventilation commenced. 
 Finally the NGT if not already in situ is placed into the stomach.” (10) 
 
 13 
 
A modified RSII has become more common in daily practice (11, 13, 14).  However, 
there is no uniform description of what modification implies (26).  Currently, the term 
modified is applied to variation in the induction agent used, the NMBA used as well as 
the technique by which it is administered, the application and timing of CP and finally 
the use of manual ventilation prior to securing the airway. (13, 14)  In a survey 
conducted in the United States of America, the majority of respondents considered a 
modified RSII to include: 
1. The administration of oxygen prior to induction of anaesthesia. 
2. The application of CP. 
3. An attempt to manually ventilate the lungs with positive pressure prior to 
intubation. (14) 
 
Although the originally described RSII is considered “standard of care” in some parts of 
the world (30), the lack of RSII protocol (owing partially to the lack of consensus of the 
various components) has resulted in a large variety of practices and techniques, when 
faced with an “at risk patient” (18). 
 
The following review will focus on those aspects of a RSII which are considered to be 
both vital to the performance of a RSII as well as those which remain controversial. 
 
2.4 Insertion of nasogastric tube  
In 1951, Morton et al. (31) in addressing the practical aspect of deaths related to 
aspiration described the use of a Ryle’s tube in the preparation of patients suspected of 
having a full stomach. The Ryle’s tube was to be placed on suction prior to induction of 
anaesthesia.  The use of gentle negative pressure was emphasised, as excessive suction 
would result in occlusion by the stomach lining or collapse of the tube itself.  Following 
aspiration of gastric fluid, performing lavage with water until the aspirates cleared, was 
suggested, the process being repeated in the prone and lateral positions.  It was noted 
that use of a Ryle’s tube was only of benefit in determining the nature of the gastric 
contents and the removal of gastric fluid just prior to induction.  The limitations 
regarding the effectiveness of the Ryle’s tube to reduce aspiration in certain scenarios, 
including intestinal obstruction, were recognised.  It was reported that in seven of the 
 14 
 
cases despite the use of a Ryle’s tube fatal aspiration did occur.  However, this was 
attributed to the incorrect positioning of the tube, poor technique and inadequate 
experience of staff (31). 
 
In 1961, Sellick (9) emphasised the danger in assuming an empty stomach after the 
above described process.  He suggested that because of the potential for incompetence 
of the upper and lower oesophageal sphincters in the presence of a NGT, there was a 
need to remove it prior to induction.  It was also noted that the tube’s presence might 
interfere with oesophageal compression when applying CP (9). 
 
Stept et al. (10) recognised the controversy of whether or not to leave the tube in situ at 
the time of induction and intubation.  In their recommendations of how to perform the 
RSII, there was no commitment with regard to either method.  Instead, it stated the 
opposing arguments comparing the risk-benefit of the NGT in its potential to facilitate 
regurgitation and conversely to provide continuous decompression of gastric contents 
(10). 
 
In 1986, the efficacy of single and double lumen NGTs for gastric decompression were 
assessed and compared.  It was found that although the double lumen sump tube was 
superior to the single lumen stomach tube in removing gastric contents; both tubes 
provided an inaccurate and unreliable means for emptying gastric contents (32). 
 
Nagler et al. (33) further examined the effect of short term intubation with a NGT on 
gastro oesophageal reflux.  It was found that the normal barriers to reflux, with a NGT in 
situ for 10 minutes, were not disrupted.  In addition, there was no apparent change in 
these barriers 10 minutes after removal of the NGT (33).  This is in contrast to studies 
conducted in critically ill patients where the incidence of oesophagitis was found to be 
increased as a result of vomiting or prolonged intubation with a NGT.  These findings 
were attributed to the slight reduction of the LOS pressure in the presence of an NGT.  
However, the observations were only made in patients who were supine, presumably 
because of the failure of gravity to assist in clearance of acid from the lower oesophagus  
(34).      
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More recently, a study to determine the effect of the NGT on LOS competence and 
pressures was conducted.  A comparison of both the pH and pressure in two groups 
undergoing elective laparotomy was conducted.  The first group was intubated with a 
NGT, pressure transducer and pH probe, whilst the second group was only intubated 
with the pressure transducer and pH probe.  It was found that although the presence of 
the NGT lowered the pressure of the LOS it was not significant enough to account for the 
observed increased incidence of gastro oesophageal reflux in the first group.  
Furthermore, it was surmised that the contributing factors to this observation were 
increased acid production, increased episodes of gastro oesophageal reflux and reduced 
clearance of refluxed acid from the lower oesophagus.  The increased acid secretion is 
thought to be the result of gastric mucosal stimulation by the NGT, which in turn causes 
vagal mediated acid secretion (35). 
 
In 1989, Dilorenzo et al. (36) showed a relationship between increased intra-abdominal 
pressure and increased lower oesophageal pressure.  This mechanism is known to 
prevent gastro oesophageal reflux in up to 92% of patients; however, there is concern 
that the presence of the NGT will impair this physiological function (36).  
 
Transient lower oesophageal sphincter relaxation is described as the abrupt decrease in 
LOS pressure to that of the intragastric pressure not triggered by swallowing.  This is 
further associated with complete and selective relaxation of the crural diaphragms.  
Transient lower oesophageal sphincter relaxation is recognised as the most common 
mechanism underlying gastro oesophageal reflux (37). It has been shown that in dogs 
and cats under anaesthesia there is complete suppression of transient lower 
oesophageal sphincter relaxation  (38). 
 
 However, pharyngeal intubation, a potent stimulus for increased transient lower 
oesophageal sphincter relaxation, independently causes an increased rate of 
occurrence, associated with the duration of pharyngeal intubation.  This is thought to be 
the result of superior laryngeal nerve stimulation.  Noordzij et al. (39) confirmed this 
hypothesis as greater relaxation of the LOS occurred with stimulation of the arytenoid 
cartilage and epiglottis (both supplied by the superior laryngeal nerve), compared to 
stimulation of the tongue (39, 40).  In contrast to previous studies it was found that 
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although laryngopharyngeal mechanical stimulation caused a reduction in LOS 
pressure, there was a paradoxical increase in the pressure of the crural diaphragm.  The 
failure of crural diaphragm inhibition precluded this reaction from fitting the criteria for 
a transient lower oesophageal sphincter relaxation.  Furthermore, there was no 
recorded case of gastro oesophageal reflux despite the reduced LOS pressure (39). 
 
The Scandinavian Clinical Practice Guidelines(17) do not include the routine insertion 
of a NGT before emergency surgery, particularly in patients at risk of organ rupture, 
cervical spinal injury or raised intraocular and intracranial pressure.  It is 
recommended, that when already present the NGT should be placed on suction to 
remove gastric content and further it should remain in situ for induction (17).  They 
support the finding of Vanner et al. (41) that presence of a NGT will not affect effective 
application of CP.    
 
2.5  Patient position   
Following preparation and procedures to decrease gastric contents and risk of 
aspiration, the patient is positioned such that should regurgitation or vomiting occur, 
the risk of aspiration is minimised.  However, there is no current agreement on the ideal 
patient position at the time of induction of anaesthesia. 
 
In Sellick’s (9) first description of CP, he commented on Morton et al.’s (31) suggestion 
to place the patient in the sitting position to allow for management of regurgitation.  
However, he cited two disadvantages to this position; first was the predisposition to 
haemodynamic instability in the critically ill patient at the time of induction and second 
the likelihood that a sitting position would facilitate the aspiration of gastric contents 
especially in the period between loss of consciousness and muscle relaxation (9).  
Instead the use of a supine or lateral position with a slight head-down tilt at the time of 
induction was advocated as it was suggested that should vomiting occur, the vomitus 
would be directed away from the airway passages aided by gravity (9). 
 
However, Stept et al. (10) encouraged the use of a V-sitting position with emphasis on 
the elevation of the trunk to 30°, which would allow gravity to counteract the effect of 
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regurgitation.  Furthermore, elevation of the feet was considered a measure to offset the 
potential haemodynamic effects of the various drugs (10).  
 
Various studies looking at the effect of the supine or semi recumbent position in 
patients in intensive care units who are mechanically ventilated with a NGT in situ, have 
shown that irrespective of position gastro oesophageal reflux resulting in micro-
aspiration occurs commonly.  However, the studies did show that in the supine group 
contamination of bronchial secretions was increased compared to both the baseline 
measurements and patients in the semi recumbent position (42-44).  Whilst these 
observations regarding patient position and aspiration can be applied primarily to the 
maintenance period of anaesthesia, there is no clear evidence for its application at the 
time of induction in the event of vomiting or aspiration.  Once the patient is optimally 
positioned and following preoxygenation, induction of anaesthesia is commenced. 
 
2.6 Induction agent 
 
The ideal agent for RSII is described as one with a fast, reliable onset of action that 
provides rapid loss of consciousness.  Furthermore, it should improve conditions for 
laryngoscopy, have minimal effects on cardiovascular parameters and possibly blunt the 
physiological reaction to laryngoscopy and intubation (18).  Table 2.1 provides a 
summary of the properties of the various induction agents pertinent to RSII.   
 
An important concept in determining effectiveness of the induction agent used is the keo 
(i.e. the first order rate constant that describes the time to equilibration between 
plasma and effect-site).  There is an almost immediate rise in plasma concentration of 
an agent following a bolus, however, there is a delay in clinical effect as the time to peak 
effect site or biophase concentration is delayed (45, 46).  This delay is the function of 
the physicochemical and molecular structures of an agent which determine the time 
taken for the agent to enter the biophase.  It is this delay which is described by the keo, a 
first order rate constant that determines the rate of onset and the end of the drug effect 
(45).  Agents with a high keo, show a long lag time between peak blood concentration 
and peak effect concentration.  These agents show an effective effect site concentration 
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at a low percentage of the plasma concentration initially achieved.  As a result, too small 
an initial bolus may show no effect at all.  Conversely, for agents with a small keo, the 
time to peak effect site concentration occurs at a higher percentage of the initial plasma 
concentration (46).  Thus, a smaller rate constant will  require a higher peak blood 
concentration to achieve the target concentration with an increased risk of unwanted 
side effects especially haemodynamically.  Whereas, a larger rate constant requires a 
lower peak blood concentration to achieve the desired effect site concentration (47).   
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Table 2.1 Properties of induction agents (48) 
 
Induction 
agent 
 Keo 
(min-1) 
Dose 
(mg/kg)a 
Effect on 
airway 
reflexes 
Haemodynamic 
effect 
Precaution/ 
contraindications 
Thiopental 0.51 3-5 mg/kg Reactive ↓BP , ↑HR 
↓CO 
↓PVR 
Direct negative 
inotrope 
Intra-arterial injection, 
extravasation into 
surrounding tissue 
causes tissue necrosis. 
Contraindicated in 
asthma. 
Propofol 0.3-0.1 1-2.5 
mg/kg 
Blunted.  
Can be 
used for 
intubation 
in 
absence 
of NMBA 
↓BP, ↔HR 
↓PVR 
High 
concentrations 
direct myocardial 
depressant 
Allergy to egg yolk, 
soybean oil, EDTA. 
Caution in shocked 
patients and elderly, 
consider reduced dose. 
Ketamine        -    1-2 mg/kg Preserved ↑BP, ↑HR, ↑CO 
Direct myocardial 
depressant in 
absence of 
endogenous 
catecholamines 
Concern over ↑ICP and 
IOP. 
Associated with 
hallucinations and 
emergence delirium.  
Increased salivation and 
bronchial secretions. 
Etomidate 0.34 0.2-0.3 
mg\kg 
Blunted b 
 
Minimal effect on 
CVS even if 
hypovolemic 
Slight ↓PVR, BP 
↔ CO, HR 
↔ contractility 
Adrenal insufficiency.  
Use with caution in 
patients who are septic 
or in septic shock.  
Consider 
corticosteroids. 
Midazolam 0.17 0.5-1.5 
mg/kg 
Blunted Minimal effect on 
CVS unless patient 
haemodynamically 
unstable. 
Respiratory depression.  
Paradoxical excitation 
especially in the young 
and elderly. 
Keo, first order rate constant that describes the time to equilibration between plasma and effect-site; BP, 
blood pressure; HR, heart rate; CVS, cardiovascular; CO, cardiac output; ICP, intracranial pressure; IOP, 
intraocular pressure. 
a The dose described only applies to the use of a predetermined dose of intubation agent. 
b In the absence of opioids poor intubation conditions. 
 
 
Originally thiopental was the drug of choice as it provides rapid loss of consciousness 
with rapid recovery.  However, it is acknowledged that in the presence of a critically ill 
or comatose patient, the rapid administration of thiopental would likely not be 
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tolerated.  Thus, in such clinical scenarios it was originally suggested that the induction 
agent be omitted (10). 
 
However, following Stept et al.’s (10) publication in 1970, numerous other induction 
agents were introduced.  In 1982, White (49) compared the use of thiopental, ketamine 
and midazolam when performing a RSII.  It was found that although onset of 
anaesthesia was on average less than 30 seconds in most patients, a quarter of those 
receiving midazolam had a delayed onset of up to 60 seconds.  Furthermore, an 
adequate depth of anaesthesia was found in all patients except one in the midazolam 
group, who proved to be a difficult intubation probably compounded by inadequate 
muscle relaxation.  Recovery was rapid except for in the group receiving midazolam 
(49). 
 
In terms of cardiovascular parameters, it was found that thiopental significantly 
decreased the mean arterial pressure whilst ketamine caused a 10% increase in the 
mean arterial pressure and a combination of ketamine and midazolam had little effect 
on the mean arterial pressure.  All combinations resulted in an increase in heart rate, 
however, this was least when a combination of ketamine and midazolam was used.  It 
was also found that thiopental was the least likely to result in amnesia, in addition to it 
being the most likely agent to require additional administration of opioids (49). 
 
In a comparison between propofol and thiopental, it was shown that propofol provided 
excellent conditions for intubation more often than thiopental.  In addition, successful 
intubation was more likely to occur in a patient receiving propofol (50).  These results 
are in keeping with Sparr et al. (51) who found that in the presence of alfentanil, 
propofol was more likely to produce good to excellent condition for intubation 
compared to a combination of alfentanil and thiopental (51).  This observation is 
thought to be the result of the greater airway depression, as well as reduced vocal cord 
adduction, when propofol is used (52).    
 
For patients with haemodynamic compromise the agents of choice are etomidate and 
ketamine.  In a study using etomidate and thiopental in combination with rocuronium 
for RSII, it was found that although intubating conditions were comparable at 60 
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seconds, etomidate attenuated the diaphragmatic response to intubation more reliably 
than thiopental (53). 
 
In 1998, Skinner et al. (54) found that following induction with propofol, the systolic 
blood pressure was significantly reduced.  However, following intubation there was an 
increase in the systolic blood pressure in both groups with that in the etomidate group 
being significantly higher.  The heart rate pre- and post-induction were comparable 
(54).  These findings were in keeping with Gill et al. (55) who demonstrated that the 
haemodynamic stability associated with etomidate induction produced a more rapid 
onset of neuromuscular blockade when compared to propofol.   
 
Hans et al. (56) looked at the effect of ketamine compared to thiopental when using 
rocuronium.  It was found that intubating conditions were adequate in the entire 
ketamine group and only half of the thiopental group.  Excellent conditions were 
reported in a significant proportion of those receiving ketamine, whilst the poor vocal 
cord conditions that were seen in a significantly higher proportion of those receiving 
thiopental, further highlighted this difference.  Finally, the mean arterial pressures prior 
to intubation were significantly higher in the ketamine group compared to the 
thiopental group, with little difference in the mean heart rates recorded (56). 
  
In a recent, multicentre randomised controlled trial the authors assessed the use of 
etomidate and ketamine when performing a RSII on acutely ill patients.  It was found 
that intubation was not affected by the choice of drug.  Furthermore safety parameters 
including change in systolic blood pressure and diastolic blood pressure, saturation and 
cardiac arrest during intubation were not statistically different.  The study did confirm 
the greater potential for adrenal insufficiency following the use of etomidate.  However, 
it acknowledged that critical illness itself has an effect on the function of the adrenal 
axis.  Finally, it found no increase in the morbidity and mortality between the two 
groups (57).  See Table 2.2 for a summary of the above mentioned studies. 
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Table 2.2 Comparison of induction agents’ effect on intubation and haemodynamics 
 
Study 
 
Induction 
agents 
compared 
 
Intubation 
conditions 
 
 
Haemodynamics 
 
Comment 
 
White et al. 
(49) 
Thiopental, 
ketamine and 
midazolam 
Intubation in, 
30s with 
thiopental and 
ketamine. 
30-60s in 25% 
midazolam. 
Thiopental ↓↓↓MAP. 
Ketamine 10% ↑MAP. 
Ketamine and 
midazolam no change 
in MAP. 
All ↑HR. 
 
Thiopental least 
likely to cause 
amnesia. 
Thiopental 
required 
additional opioid 
administration. 
 
Dobson et al. 
(50) 
Propofol and 
thiopental 
Propofol 
superior 
intubating 
conditions. 
 Successful 
intubation more 
likely with 
propofol. 
 
Sparr et al. 
(51) 
Propofol, 
etomidate, 
alfentanil 
with propofol 
and alfentanil 
with 
thiopental 
Alfentanil and 
propofol 
superior 
intubating 
conditions. 
 Propofol greater 
airway depression 
with less vocal 
cord adduction. 
 
Fuchs-Buder 
et al. (53) 
Etomidate 
and 
thiopental 
Comparable 
intubating 
conditions at 60 
s. 
 
  
Skinner et al. 
(54) 
Etomidate 
and propofol 
 Significant ↓in SBP 
with propofol. 
Following induction 
↑SBP etomidate> 
propofol. 
 
 
Hans et al. (56) Ketamine and 
thiopental 
Intubating 
conditions 
adequate in 
100% ketamine 
cases vs 50% of 
thiopental cases. 
 
Higher MAP with 
ketamine. 
HR equivalent. 
Poor vocal cord 
conditions 
significantly 
higher with 
thiopental. 
Jabre et al. (57) Ketamine and 
etomidate 
Intubating 
conditions 
equivalent. 
SBP, DBP and SATS 
comparable. 
No difference in 
morbidity and 
mortality between 
the two groups. 
MAP, mean arterial pressure; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; SATS, 
oxygen saturation. 
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From the preceding text, it is clear that it is the patient’s clinical status which may 
influence the choice of induction agent to be used.  This is further determined by the 
choice of NMBA used.  When succinylcholine is used for RSII, the choice of the induction 
agent used has little effect on intubating conditions.  However, propofol has proven 
superior when using rocuronium.  In addition in patients in whom hypotension would 
not be well tolerated, etomidate or ketamine would be the agent of choice (18). 
The other controversy surrounding induction agents is the use of a predetermined dose 
versus titration to effect.  Originally Stept et al. (10) described the use of a 
predetermined dose of thiopental.  However, the use of predetermined doses is 
associated with the risk of either underdosing and awareness or overdosing and the 
potential for haemodynamic instability (26).  Thus, the use of titration to effect has been 
advocated to not only reduce the dose of agent administered and therefore the potential 
for cardiovascular side effects, but also to prevent awareness as the endpoint is loss of 
consciousness.  There is concern that titration will delay administration of the NMBA 
and as a result increase the risk-interval for aspiration (18). However, Barr et al. (58) 
showed that there was no appreciable difference between time to intubation between 
the two techniques.  Contrary to belief they demonstrated a shorter time to intubation 
in the titration group (58).  There is a paucity of data comparing the risk of aspiration 
with a longer induction time, haemodynamic stability and awareness in groups using 
both the predetermined and titration techniques for induction (18). 
 
Finally, there is data looking at the effect of intravenous agents, more specifically 
propofol and dexmedetomedine, on the lower oesophageal sphincter(59) pressure (60-
62).  However, the majority of these studies either look at infusions of these agents for 
sedation (60, 62), or the effect of propofol in conjunction with cricoid pressure on lower 
oesophageal sphincter pressure.  Furthermore, doses quoted were less than those 
usually used for induction (59).  The literature varies quoting a linear relationship 
between depth of anaesthesia and a decrease in lower oesophageal sphincter tone (62).  
Conversely other studies found little appreciable change in the pressure (59, 61, 63).  
Thus, additional studies looking at induction doses of commonly use induction agents 
and the effect on lower oesophageal sphincter tone would be necessary to determine 
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whether there truly is a benefit to fixed versus titrated doses in the prevention of 
aspiration. 
 
2.7 Cricoid Pressure 
One of the most controversial aspects of the RSII has been the use of CP.  A recent 
review article by Priebe (64) discussed some of the more pertinent aspects of CP in the 
literature.  The most important controversy exists around the effect of CP on the 
management of an emergency airway in addition to the actual effect on anatomy at the 
time of use.  CP is the application of backward pressure on the cricoid ring resulting in 
occlusion of the oesophagus against the 5th cervical vertebra (64, 65).  Its application 
was reported to prevent the presence of regurgitated material or vomitus into the 
pharynx (18, 64).   
CP has been shown to reduce the risk of gastric insufflation with manual ventilation 
especially in the paediatric population (see section on Bag mask ventilation in RSII).  
However, it was associated with an increased incidence of airway obstruction and 
reduced tidal volumes, which prevented adequate ventilation in some patients.  The use 
of CP has been suggested as one of the main causes for the increased incidence of a 
difficult airway in an emergency situation.  The application of CP results in a highly 
variable effect on conditions for laryngoscopy but, with application of the suggested 10-
40 N it was found that more often than not the laryngeal grade worsened.  There is 
evidence that the amount of force applied correlates with the degree to which 
laryngoscopy is affected.  In the event that a rescue airway is required, it has been 
demonstrated that successful insertion of a laryngeal mask airway is reduced in the 
presence of CP.  Additionally successful intubation through the laryngeal mask airway is 
also impaired (64-66). 
The application of CP was originally described with the neck in extension, however, 
preliminary data was collected in patients in whom hyperextension was applied to 
achieve positive pressure ventilation and intubation (9, 18, 64).  There is some concern 
that this hyperextension would cause tethering of the oesophagus, but result in less 
evident or absent occlusion in the more commonly used sniffing position (18, 64).  In 
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the report, Sellick (9) did not describe the amount of pressure applied during the 
manoeuvre and there was no standardisation of the anaesthetic performed (64, 65).   
However, despite these limitations the study demonstrated the ability to prevent 
aspiration up to 100 cmH2O.  This in addition to the presence of gastric contents in the 
pharynx on release of CP in 6 patients, resulted in CP becoming standard of care (9).  
Subsequent studies conducted primarily on cadavers involved the instillation of H2O or 
saline into the oesophagus.  It was demonstrated that CP reliably prevented presence of 
gastric contents in the pharynx up to 100 cmH2O (64, 65). 
In contrast to the cadaveric studies, magnetic resonance imaging studies demonstrated 
an increase in lateral displacement of the oesophagus from 53 to 91% with the 
application of CP.  There was an additional increase in the incidence of incomplete 
occlusion when the oesophagus was already laterally displaced.  Furthermore, it was 
found that the application of CP itself caused lateral oesophageal displacement and an 
increased incidence of failure to oppose the oesophagus against the underlying 
vertebrae (26, 64-66). Currently it is believed that it is not the oesophagus which is 
occluded but rather the hypopharynx which acts as an “anatomical unit” when occluded 
and as a result displacement of the oesophagus is immaterial (64, 66).  Rice et al. (67) 
also demonstrated that regardless of lateral displacement there is still occlusion against 
the left longus colli muscle.  Concern has arisen over the elasticity of the muscle 
compared to the bone, and thus potential for oesophageal expansion when regurgitated 
material is present in the upper oesophagus (64, 66). 
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Figure 2.1. “Axial magnetic resonance images in the sniffing position, without (A) and with (B) cricoid 
pressure. A, shows the postcricoid hypopharynx (arrow) and the Vitamin E marker (arrowhead) placed 
by the anesthesiologist before imaging. C, an example of postcricoid hypopharynx compression (arrow) 
lateral to the vertebral body with cricoid pressure. In this image, the postcricoid hypopharynx is 
compressed against the longus colli muscle group (arrowhead). D, an image 2 cm inferior to the cricoid 
ring distinctly showing the cervical esophagus (arrow) lateral to the vertebral body. In Panels (B) and (C), 
the anesthesiologist’s thumb and index finger can be seen pushing on the cricoid cartilage. The axial 
image chosen for each study (A–C) was the image at the most inferior level of the cricoid cartilage.”(67) 
 
There is evidence that CP has a physiological influence on the functioning of the LOS 
(64, 65).  Closure of the upper oesophageal sphincter at the end of swallowing causes 
the LOS to open.  As the application of CP mimics the action of the upper oesophageal 
sphincter, the studies have shown that CP causes relaxation of the LOS and thus 
potentially increases the risk of aspiration as well as gastric insufflation with positive 
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pressure ventilation (64, 65).  See Table 2.3 for the normal gastric and LOS pressures 
and how these pressures are affected by various scenarios. 
Table 2.3 Intragastric and lower oesophageal sphincter pressure 
 Gastric 
pressure 
Lower oesophageal pressure 
Normal < 7 mmHg 38 mmHg 
Spontaneous reflex vomiting 25-35 mmHg 45 mmHg 
Fasciculation from 
succinylcholine 
40 mmHg 45 mmHg 
General anaesthesia  7-14 mmHg 
Cricoid pressure  Decreases ++ 
Reproduced with permission from Prof. A Milner 
 
The timing of CP application and the force to be used is widely varied and debated. 
Sellick (9) advised the cricoid cartilage be identified and held “lightly” between the 
thumb and second finger.  With induction of anaesthesia the pressure applied was to be 
increased to a “firm” pressure.  In one of the articles, it was stated that even a conscious 
patient would tolerate “moderate” pressure (9). When Stept et al. (10) described its 
application in the RSII, the timing of the CP was to coincide with loss of consciousness.  
Subsequently, there have been suggestions that the application of “light” (previously 
equating to 20 N and more recently 10 N) in an awake patient should be well tolerated 
(64, 65).  The arguments against its application in the conscious patient include patient 
discomfort, obstruction to ventilation, retching and vomiting.  This is further 
compounded by the risk of oesophageal rupture in a patient vomiting against applied CP 
(66). 
The amount of force that is adequate to prevent aspiration is once again indeterminate.  
Previously it was believed that a force of 44 N should be applied, this was later revised 
to a firm force of 30 N.  It was found however, that despite theoretical knowledge of 
force to be applied; practically there was a wide variation in both technique and 
pressure used.  Application of CP was shown to be superior when applied by an 
experienced anaesthetist or following training (64-66). 
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Additional quoted risks of CP include conjunctival haemorrhage if a patient coughs 
whilst CP is applied, haemorrhage into a goitre, haemodynamic effects and concern over 
the potential to cause movement in a cervical spinal injury (65). 
However, advocates of CP argue that the adverse events associated with this manoeuvre 
are the result of infrequent use of CP as well as incorrect application, timing, technique 
and use of the incorrect amount of force.  Another subset of practitioners argue that the 
risk associated with the manoeuvre is low and because of its potential to prevent 
aspiration in a certain percentage of patients, the use of CP should be continued (18).     
With regards to CP in the paediatric population specifically, a survey conducted in the 
UK including members of the Association of Paediatric Anaesthetists, it was found that 
only 40-50% of anaesthetists used CP during emergency surgery on a child (68).  The 
reason for this reduced incidence may be associated with two factors, namely the 
anatomical difference of the paediatric airway under eight years of age as well as the 
potential to distort the laryngeal view and thus potentially affect airway management.   
It has been found that lateral displacement of the oesophagus occurs in a significantly 
greater proportion of children less than eight years of age when CP is applied 
[difference in rates was 30% (95% CI 14%-46%)] (69).  Furthermore, Walker et al (70) 
found that the force necessary to occlude the airway by at least 50% in the less than 
eight years of age group, is significantly less with a mean of 10.5 N and as little as 5 N for 
those less than one year of age.  Thus, use of CP at forces typically used for adults (30 N) 
could seriously compromise the ability to efficiently manage the paediatric airway in an 
emergency (70).  However, the current recommendations for cricoid pressure in 
children is for between 22.4 N and 25.1 N (71).  With the development of a controlled 
RSII as advocated for the paediatric population, the use of CP may further fall out of 
favour.    
The relatively low incidence of aspiration does not allow for a study to determine the 
effect of CP on the incidence of aspiration.  Furthermore, as it is considered standard of 
care it is unlikely to get ethics approval to conduct a randomised controlled trial to fully 
determine the effectiveness of CP. (18, 64, 65)  What is apparent from studies on 
current practice is that the technique, timing and use of CP in the RSII is variable (11-13, 
15, 16). 
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2.8 Neuromuscular blocking agent 
Following the introduction of succinylcholine in 1951, it was incorporated into the 
classic RSII method (10, 18).  Questions regarding the optimal dose of succinylcholine 
have resulted in multiple studies and reviews.  It was noted that although a dose of 1 
mg/kg provided optimal and rapid paralysis, the duration of blockade tended to exceed 
the duration necessary for desaturation (72).  Thus, in 2004 El-Orbany et al. (72) 
studied the effect of a reduced dose of succinylcholine on both the duration of action 
and intubating conditions.  As an additional aim they looked at the effect of the reduced 
dose on intubation conditions.  It was found in two separate studies, that a dose of 0.6 
mg/kg was as effective in providing 100% twitch depression, although the time to 
maximal effect was slightly prolonged in the 0.6 mg/kg group (72, 73).  
Similarly Naguib et al. (74) found that there was no significant difference in intubating 
conditions at 60 seconds between 0.56 mg/kg and 1 mg/kg of succinylcholine (74).  It 
was further noted that the time to either 10% twitch recovery of adductor pollicis or 
sustained spontaneous ventilation was dose dependant with an average time of 4 
minutes in the 0.6 mg/kg group compared to 6 minutes with 1 mg/kg. Thus, 
spontaneous respiration prior to desaturation (saturation <90%) was more likely to 
occur in patients receiving the lower dose (72, 75). 
However, despite the rapid onset and the optimal conditions succinylcholine provides 
for laryngoscopy, the poor side effect profile has resulted in the development of 
alternative agents.  Side effects of concern include: 
 hyperkalaemia (especially in burns victims, spinal cord lesions and prolonged 
immobility) 
 scoline apnoea 
 malignant hyperthermia  
 masseter muscle spasm 
 raised intracranial and intraocular pressure 
 bradycardia or transient cardiac arrest (especially in children) 
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 myalgia and fasciculation. 
 Vecuronium gained popularity in the 1980s with much of the literature focusing on the 
priming and timing techniques (76-78).  However, as it is an intermediate acting agent 
with an onset of two to three minutes, when administered in the conventional manner 
time to optimal conditions for intubation would increase the risk of aspiration.  It was 
found that by giving a priming dose of 0.015 mg/kg of the 0.1 mg/kg total dose two to 
three minutes prior to induction, the onset was reduced to an average of 60 seconds.  At 
the time, the authors thought the onset and laryngoscopy conditions to be comparable 
to succinylcholine but with the absence of undesirable side effects (76). 
The unpredictability and long duration of action associated with the priming technique 
prompted a study looking at the timing principle whereby patients were given the full 
dose of vecuronium with the induction dose only being administered with the onset of 
weakness.  Once again they found intubating conditions to be comparable to 
succinylcholine at 60 seconds although deep blockade was questioned in the face of 
haemodynamic responses to laryngoscopy (77).  Similar studies and conclusions were 
seen in a study using the timing principle with atracurium  (79).  In 1990, a study 
comparing the two different techniques with vecuronium and succinylcholine showed 
little difference in the intubation scores between the priming technique and 
succinylcholine; however, there was a marked increase in time to recovery of first 
twitch in the train-of-four in both the priming and timing group (78).   
Controversy exists regarding the safety of both the priming and to a lesser extent the 
timing dose in patients at risk of aspiration.  Although it has been shown that a priming 
dose of 10% of the total dose to be administered is unlikely to cause little more than 
heavy eyelids, blurred vision, and difficulty in swallowing, there is a subset of patients 
who will exhibit more serious adverse effects including the inability to swallow.  Patient 
sensitivity to the effects of a non-depolarising NMBA, is not predictable thus placing 
such patients at increased risk should aspiration be a real concern (80). 
The popularity of rocuronium is attributable to the rapid onset and excellent 
laryngoscopy conditions.  Two studies to determine the optimal dose of rocuronium for 
RSII have shown that conditions comparable to those of succinylcholine are achieved 
with a dose of 1.0-1.2 mg/kg (81, 82).  Furthermore, it was demonstrated that 
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regardless of the dose of rocuronium, the intubating conditions were superior when 
using rocuronium with propofol as opposed to the other commonly used induction 
agents (50).  However, concern arose as the duration of action was dose related, lasting 
up to one hour with the recommended dose.  The introduction of sugammadex is likely 
to change the practice of NMBAs used in RSII as it will provide rapid reversal of 
rocuronium, even in the face of deep blockade.  Initially, it was  thought that the time to 
reversal would be comparable if not more rapid than the time taken for recovery from 
succinylcholine (83).  However, what has emerged is that the time to recovery of 
spontaneous ventilation, recovery of T1 10% and recovery of T1 90% from both time of 
injection and intubation, is more rapid with rocuronium-sugammadex compared to 
succinylcholine.  In terms of safety profile both drugs appear well tolerated (84, 85). 
Suggamadex is currently not available in state hospitals although it has become 
available in the private sector.  The cost per ampule is approximately R830.00 and 
reversal from neuromuscular blockade would require between one and four ampules.  
As a result the South African Society of Anaesthesiologists issued a position statement 
on the use and supply of suggamadex in September 2015.  The position they hold is for 
the responsible use of suggamadex by clinicians in situations (emergency cases, difficult 
airways or patient benefit perioperatively) deemed appropriate.  In addition they 
advocate the use of neuromuscular transmission monitoring as a minimum, to guide 
Suggamadex use(86).    
Gantracurium, an onium fumarate, is a non-depolarising muscle relaxant that has a 
rapid onset, is ultra-short acting and provides comparable conditions to succinylcholine.  
In its favour is the lack of adverse side effects as well as the presence of a naturally 
occurring reversal agent resulting in reversal of paralysis within three minutes of an 
intubating dose (83). 
 
2.9 Preoxygenation 
Rapid sequence induction is associated with an increased incidence of a difficult airway 
and failed intubation compared to the population of patients undergoing elective 
induction, particularly outside the operating theatre (87-89).  Preoxygenation forms 
part of the originally described RSII.  The purpose of preoxygenation is to fully 
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oxygenate or denitrogenate the function residual capacity (FRC) thereby providing a 
reservoir for on-going oxygenation during the period of apnoea.  This allows the 
provider a longer duration of apnoea without desaturation and thus, to secure the 
airway (90). 
There are various studies that have looked at surrogate markers of adequate 
preoxygenation, including arterial oxygen partial pressure, achieving a saturation of 
100%, an end-tidal oxygen fraction of greater than 0.9, end-tidal nitrogen or carbon 
dioxide fraction of less than 0.05, in order to delay the time to desaturation (90).   
Two techniques of preoxygenation have been described, namely the slow and fast 
techniques.  In the slow technique the anaesthetic circuit is primed with 100% oxygen 
and the facemask is placed with a good seal over the patient’s face.  The patient is asked 
to inhale at normal tidal volume for three minutes (3 TVB) or until an end-tidal oxygen 
fraction of greater than 0.9 is achieved.  The fast technique involves the patient 
hyperventilating in an attempt to preoxygenate the FRC more rapidly.  Two methods to 
achieving fast preoxygenation are described including four deep breathes (4 DB) over 
30 seconds and eight deep breathes (8 DB) over 60 seconds (90, 91). 
In a study comparing the 3 TVB to the 4 DB in 30 seconds, it was found that the 3 TVB 
was superior in achieving adequate preoxygenation (92).  Furthermore when the 4 DB 
in 30 seconds and 8 DB in 60 seconds fast methods were compared, it was found that 
once again the 4 DB in 30 seconds was the inferior method (93-95).  When the three 
minute tidal volume breathing was compared to the eight deep breathes in 60 seconds 
it was found that the markers, namely end-tidal oxygen fraction and duration of apnoea 
without desaturation, were comparable (90).  
It is suggested that in the emergency setting the use of the fast 8 DB in 60 seconds may 
be the technique of choice provided the patient is co-operative (90).  Further 
considerations with regard to preoxygenation include special patient groups and 
patient position.  Patient populations of concern include the pregnant, obese, paediatric, 
elderly, those with increased metabolic rate as well as the critically ill.  These are often 
the subset of patients presenting for emergency surgery, requiring a RSII.  However, 
despite adequate oxygenation these patients may still show shorter duration of apnoea 
without desaturation.  (90, 91, 96) 
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To optimise these patients prior to induction patients can be placed in a head-up 
position rather than supine as this increases the FRC.  There is also a suggestion of 
applying positive end expiratory pressure with 100% oxygen in an attempt to reduce 
atelectasis and recruit alveoli (90). Weingart (91) suggested that in the high risk 
patients application of non-invasive ventilation may be applicable .  However, this once 
again requires a co-operative patient. 
Despite the improved preoxygenation seen in morbidly obese patients when continuous 
positive airway pressure is applied, it is recognised that time to desaturation is not 
significantly improved.  This is thought to be the result of a return to pre continuous 
positive airway pressure volume in the FRC once the continuous positive airway 
pressure mask is removed for intubation (97).  In later studies, the use of 10 cmH2O 
continuous positive airway pressure together with oxygen during preoxygenation for 
five minutes, has been shown to in fact increase the time to desaturation in obese 
patients (98, 99).  In addition, this technique is associated with only 2% atelectasis 
compared to 10% in the non- continuous positive airway pressure group, as seen on 
computed tomography (99).  Delay et al performed a randomized controlled study in 
which they looked at the impact of preoxygenation using non-invasive ventilation 
including pressure support of eight cmH2O and positive end expiratory pressures of six 
cmH2O, they found that 95% of patients achieved the target expiratory fraction of 0.9 
compared to only 50% in the oxygen only group.  However, it was noted that despite 
this improvement in preoxygenation, no difference in arterial blood gas was noticeable 
five minutes post intubation between the groups (100). 
In 2007, Baraka et al. (101) looked at the effect of nasal oxygen insufflation in the 
morbidly obese patient.  They found that insufflation of 100% oxygen via a nasal tube 
increased the mean time to desaturation in morbidly obese patients, following adequate 
preoxygenation.  It is thought that the sub atmospheric pressure created by the 
movement of oxygen from the FRC into the capillaries, allows the movement “en masse” 
of the ambient oxygen into the lungs (101).  There is concern that both continuous 
positive airway pressure and nasal oxygen insufflation may lead to gastric insufflation 
in a patient already at risk of aspiration. 
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There is literature addressing the possibility of maintaining a spontaneously breathing 
patient after induction to allow adequate and additional preoxygenation prior to muscle 
relaxation.  This is particularly of interest in the hypoxic and hypercapnic patient who 
may be uncooperative and not allow adequate preoxygenation whilst still conscious 
(91).  
 The method of delayed sequence induction that is proposed by Weingart (91) includes 
the use of an induction agent such as ketamine or dexmedetomedine to induce the 
patient, prior to preoxygenation, whilst still maintaining spontaneous ventilation and 
airway reflexes.  This is followed by preoxygenation to achieve a saturation of 100%, 
with an additional two to three minutes of oxygenation to achieve denitrogenation.  The 
muscle relaxant is administered with apnoea occurring in 45 to 60 seconds and the 
airway is then secured.  There is also some thought that the use of an induction agent in 
sedative doses may allow improvement of respiratory parameters precluding the need 
for intubation in the emergency department (91).  
The latest concept in preoxygenation is transnasal humidified rapid insufflation 
ventilatory exchange or “THRIVE”.  It combines the use of modest continuous positive 
airway pressure for preoxygenation via high flow transnasal insufflation of humidified 
100% oxygen and the concept of aventilatory mass flow to extend the period of apnoeic 
oxygenation and thus the time to hypoxaemia (102, 103).  Preoxygenation is achieved 
with flow rates as high as 70 l.min-1 (102).  In one study the apnoeic time was extended 
to a mean time of 17 minutes without desaturation to values below 90%. There is still 
some concern over the inability to remove carbon dioxide which thus increases linearly 
(102).  However, Patel et al (102) failed to demonstrate any of the commonly associated 
problems with carbon dioxide toxicity including cardiac arrhythmias. 
 
2.10    Bag mask ventilation in the RSII 
The classically described RSII emphasised the negation of bag mask ventilation 
following induction of anaesthesia and onset of apnoea until the airway was 
successfully secured (10).  For many years literature has supported the notion that in 
the case of aspiration risk, avoidance of positive pressure ventilation is necessary to 
avoid insufflation of the stomach and further contribute to the risk of regurgitation and 
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vomiting.  However, recognition of the high proportion of patients at risk of hypoxaemia 
who undergo RSII supports the argument for manual ventilation (30). 
In a study done by Lawes et al. (104) in 1987 it was recognised that with sufficient 
preoxygenation and the use of a rapid NMBA, there is often no need for bag mask 
ventilation.  However, under certain circumstances with the rapid onset of hypoxia, 
manual ventilation would be required to prevent adverse sequelae (90, 104).  It was 
identified that the use of a priming technique with the NMBA would be a situation in 
which CP and the application of manual ventilation would still be prevalent (104). 
Subsequently, it was demonstrated that in the absence of CP a minimum pressure of 20 
cmH2O was necessary to cause gastric insufflation.  This pressure was lower than the 
mean pressure of 16,5 cmH2O necessary for adequate respiratory excursion.  
Furthermore, with the application of CP the peak circuit pressure generated was 44,7cm 
H2O and at no pressure was gastric insufflation recorded.  These pressures are possible 
provided the CP is correctly applied.  They also made a comment on the risk of 
occluding the airway and preventing adequate ventilation with the application of CP 
particularly in the elderly (104). 
In 1989, Petito et al. (105)  did a study on low risk patients to determine the difference 
in gastric insufflation between those in whom bag mask ventilation was performed both 
with and without CP.  In the control group the amount of gas aspirated after ventilation 
of two minutes was between 0 to 1000 mls with an average of 168 mls.  In comparison, 
when CP was applied aspirates of 0 to 580 mls with an average of 39 mls was aspirated, 
once again highlighting the role of CP in decreasing gastric insufflation.  Of note was the 
observation that patients who were difficult to bag mask ventilation had similar 
aspiration volumes regardless of whether or not CP was applied (105). 
The risk of gastric insufflation with bag mask ventilation in infants and children is 
associated with not only an increased risk of gastric aspiration but also a reduction in 
the FRC as well as venous return and cardiac output.  In a study conducted on 59 
children between the ages of two weeks and eight years, it was found that CP reduced 
the gastric insufflation in 100% of cases regardless of paralysis.  They observed that 
gastric insufflation occurred at lower peak inspiratory pressures in the presence of 
paralysis; however, they noted that the presence of CP tended to increase the pressure 
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at which gastric insufflation occurred in the presence of paralysis. (106) Finally their 
finding that insufflation was unlikely at peak pressures of less than 15 cmH2O with or 
without CP, which was in keeping with the findings of Lewis et al. (104).  
The Difficult Airway Society in the United Kingdom (UK) published guidelines on RSII 
performance in which they state that gentle manual ventilation at pressures of less than 
20 cmH2O is considered acceptable practice by some of the more experienced 
practitioners (24, 30).  The change in practice to allow gentle positive pressure 
ventilation either before and/or after administration of a NMBA was confirmed in a 
recent survey in which 94% of the respondents regarded it acceptable to attempt 
manual ventilation during a RSII (13). 
 
2.11 Current practice 
From 2001to 2016 there have been  five studies looking at the variation and current 
trends in the performance of a RSII by anaesthetists, in various institutions including in 
Wales, the UK, the USA and Germany (11, 12, 14-16).    
 
In a national survey on the practice of RSII in the UK, Morris et al. (12) found that 
preoxygenation was used by 100% of respondents.  However, the method in which 
preoxygenation was achieved varied from the use of 100% oxygen for three minutes by 
82% of the respondents, to the use of a vital capacity based breathing techniques in the 
minority. (12) Similarly, Ehrenfeld et al. (14) found that all respondents in the USA 
administered oxygen to patients prior to induction of anaesthesia.  However, the exact 
method by this was achieved was not stated.  Instead it was noted that preoxygenation 
generally lasted between three and five minutes, with no appreciable difference 
between trainee anaesthetists and anaesthesiologists (14).   
 
The most recent survey conducted in the UK by Sajayan et al. (15) found that of the 
respondents only 1 trainee and 3 consultants did not routinely perform preoxygenation.  
The most common technique adopted by respondents was to monitor the end tidal 
oxygen concentration, looking for a value of greater than 0.9.  Other techniques used 
included 3 minute tidal volume breathing, 1 minute vital capacity breathing and a 
 37 
 
combination (15).  Although preoxygenation was used by the majority in Germany, use 
of an end tidal oxygen concentration to determine adequacy only accounted for 
approximately 40% of the techniques used (16). 
 
The use of continuous positive airway pressure during preoxygenation was an 
additional technique for preoxygenation in the UK.  Of the respondents 42% stated that 
they used continuous positive airway pressure, with the majority being used for the 
preoxygenation of obese patients.   They further found that 76% of the respondents 
routinely used a head up position of 20-25° for preoxygenation, whilst a further 11% 
chose a head up  tilt of 45°. No mention was made of the position adopted at the time of 
induction(15). Use of the head up position was also most commonly described in the 
German survey with only 3% adopting the Trendelenburg position (16). 
 
NGT insertion was used by 65% of the German respondents when performing a RSII for 
a small bowel obstruction.  The NGT was placed prior to induction of anaesthesia and 
left in situ throughout (16). 
   
The most commonly used induction agents in the UK were thiopental (88%), propofol 
(58%) and etomidate (54%) with midazolam and ketamine being used by only a small 
minority.  In Wales, it was found that the use of propofol for induction had exceeded 
that of thiopental.  However, in specific clinical scenarios, namely caesarean section and 
bowel obstruction, thiopental and etomidate respectively, were considered the 
induction agent of choice.  In contrast to the study in 2001 in the UK, Sajayan et al. (15) 
found that propofol was the most commonly used induction agent particularly amongst 
the consultants, whilst a larger proportion of trainees still used Thiopentone most 
commonly.   
 
Only the study from Wales looked at the use of predetermined and titration techniques 
for administration of the induction agent.  It was found that amongst anaesthetists there 
was no significant difference between those that chose predetermined doses compared 
to those that chose to use the titration method.  Furthermore, there was no difference 
between trainee anaesthetist and anaesthesiologists in terms of technique preference 
(11). 
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Opioid use during RSII occurred in 80% of respondants in the 2016 UK survey.  
Although reported use was higher in consultants, the difference was not significant 
(p=0.022).  The most commonly used agent was fentanyl followed by alfentanyl, 
remifentanil and morphine respectively (15). 
 
CP was applied by all the respondents in the original UK study (12) and 86-94% in the 
USA study (14).  In contrast, Sajayan et al. (15) showed that CP was only applied 92% of 
the time with the remaining 8% choosing to use CP for select cases only.  It was also 
found that of the respondents, trainees were more likely to always apply CP compared 
to the consultants (15).  Conversely, in Germany only two thirds of the respondents 
used CP.  Of those respondents, only 50% viewed two specific clinical scenarios, namely 
small bowel obstruction and upper gastrointestinal bleeding, as indications for CP (16).   
The timing of application was during the induction of anaesthesia in the majority of 
respondents in both of the UK studies and the USA survey. (12, 14, 15)  In the German 
study, the majority applied cricoid pressure only once the patient was asleep (16).   
 
Other interesting observations with regard to the use of CP from the Germany survey, 
included the practice of reducing or releasing CP, by two-thirds and one-third of 
respondents respectively, should the initial attempt at intubation fail.  It was also noted 
that 25% of the respondents had observed an episode of regurgitation either at the time 
of CP application or following its release.  It was further found that the incidence of an 
observed regurgitation increased in accordance with the number of years of experience 
of the respondents (16). 
 
Koeber et al. (11) found that the clinical scenario dictated the use of a cuffed tracheal 
tube and CP such that for bowel obstruction 100% of respondents used CP, but for an 
asymptomatic hiatal hernia only 25% would use CP (11). 
 
The use of bag mask ventilation prior to administration of NMBAs was considered to be 
a defining feature of a modified RSII in the USA (14).  The likelihood of using bag mask 
ventilation during a RSII was higher in anaesthesiologists compared to trainee 
anaesthetists.  Bag mask ventilation was more commonly practiced by 
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anaesthesiologists for moderate to morbidly obese patients, as well as those with gastro 
oesophageal reflux.  The majority described limiting bag mask ventilation to less than 
five breathes in an attempt to ventilate the lungs prior to muscle relaxation. (14)  In the 
UK, only 17% of respondents used “gentle” bag mask ventilation following apnoea, 
whilst a further 6% chose to use oxygen insufflation via a nasal catheter (15). 
 
Succinylcholine still remains the most commonly used agent for neuromuscular 
blockade.  However, it was found that of the respondents in the UK, trainee 
anaesthetists were more likely than anaesthesiologists to use rocuronium routinely in a 
RSII The majority of respondents in the UK (12, 15) and Wales (11)only administered 
NMBAs after signs of loss of consciousness were recognised, which is in contrast to the 
traditional technique which called for the administration of succinylcholine 
immediately following induction (10).  In Germany the majority of respondents use 
either succinylcholine(70%) or rocuronium(40%).  However, the use of rocuronium 
was more common amongst respondents at an academic hospital as compared with 
those at either a district or community hospital.  There were a further 24% who use 
both the priming and timing techniques when using a NDMR (16). 
  
The Wales (11)study concluded that the use of a RSII was less often employed by 
anaesthesiologists compared to trainee anaesthetists.  Furthermore, when performing 
the RSII the anaesthesiologists were less likely to use the classic combination of 
thiopental and succinylcholine (11). 
 
A lot of emphasis has been placed on the use of a classically described RSII and whether 
it is still appropriate for use in the paediatric population.  A retrospective study 
conducted on children aged three to twelve years of age showed that despite 
preoxygenation the risk of hypoxia (saturations <90%) was 3.6% with severe 
hypoxaemia (saturations <80%) occurring in 1.7%.  Furthermore, incidence of 
bradycardia and hypotension were 0.8% and 0.5% respectively.  As a result an 
alternative approach described the controlled RSII is being advocated in the paediatric 
population (107).  This approach includes: 
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 “continuous aspiration on an NGT if in situ or the insertion of one after the 
tracheal tube is secured 
 patient positioned head up at 20° for preoxygenation and induction 
 titration of an induction agent to produce unconsciousness followed by the use of 
atracurium at 1mg/kg (although any NMBA may be used provided optimal 
relaxation is guaranteed, thus advocating the use of neuromuscular block 
monitoring) 
 gentle bag mask ventilation (keeping insufflation pressures <12 cmH2O) before 
intubation 
 intubation following loss of all twitches on the train-of-four, on a nerve 
stimulator, thus ensuring a deep level of anaesthesia and adequate 
neuromuscular blockade.”(108) 
 
2.11 Conclusion 
From the above literature it is clear that many controversies still exist with regard to 
performing a RSII.  There still exists debate as to the appropriate use of a NGT, CP and 
bag mask ventilation.  The absence of internationally standardised guidelines has 
resulted in a variety of techniques to achieve rapid induction and intubation largely 
based on the patient status, clinical scenario and level of experience.  The concern over 
the incidence of aspiration provides a setting for a review of current practice with 
regard to RSII in the University of Witwatersrand’s Department of Anaesthesiology. 
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Chapter 3  
3.0  Research Methodology 
3.1 Introduction 
This chapter will describe the research methodology of the study.  It will include 
research design, study population, the sampling process and study methods. 
The problem statement, aims and objectives from Chapter 1 will be repeated to ensure 
consistency. 
 
3.2 Aim and objectives 
3.2.1 Aim 
The aim of this study was to describe the current practice of anaesthetists in the 
Department of Anaesthesiology at Wits when performing a RSII using seven clinical 
vignettes. 
3.2.2 Objectives 
The primary objectives of this study were to: 
 determine the proportion of anaesthetists who recognise patients at risk of 
pulmonary aspiration; 
 describe the choice of induction agent used for a RSII; 
 describe the choice of NMBA used for a RSII; 
 describe the technique used when performing a RSII. 
The secondary objectives of this study were to: 
 compare the difference in technique between the consultant and trainee 
anaesthetists; 
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 compare the difference in induction agents between the consultant and trainee 
anaesthetists; 
 compare the difference in NMBA between the consultant and trainee 
anaesthetists; 
 describe the anaesthetists definition of a modified RSII. 
 
3.3 Ethical considerations 
Approval to conduct this study was obtained from the Graduate Studies Committee 
(Appendix A) and the Human Research Ethics Committee (Medical) of the University of 
the Witwatersrand (Appendix B).   
The study was conducted prospectively and the identifying information of the 
respondents remained anonymous.  Anaesthetists in the Department of Anaesthesiology 
at Wits, were invited to take part in the study and those that agreed were given an 
information letter (Appendix C).  Informed consent was implied by completion of the 
questionnaire.  Questionnaires were sealed in an envelope and returned to a secure box.  
Participation in the survey was voluntary, thus, respondents could withdraw from the 
study at any time should they so choose. 
All the data collected was kept confidential as only the researcher and supervisors had 
access to the raw data.  The data will be stored securely for six years after completion of 
the study. 
The study was conducted adhering to good clinical research practice in accordance with 
the South African Good Practice Guidelines (19) and the Declaration of Helsinki (20).   
Should the audit find that the identification of at risk patients by anaesthetists at Wits is 
poor, further education and training will be suggested to improve patient outcome. 
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3.4 Research methodology 
3.4.1 Study design 
The research design used in this study was a prospective, contextual, descriptive design.  
A prospective study is defined as a study in which individuals are selected because of 
specific factors that are to be examined for an outcome.  In this study questionnaires 
were completed by anaesthetists and the clinical practices of RSII determined. 
The context refers to a body or world and the concerns unique to the individuals arising 
from this world (109).  The study was contextual as it only evaluated the current 
practice of RSII amongst the anaesthetists in the Department of Anaesthesiology 
affiliated to Wits. 
A descriptive study is used to identify phenomena and the associated variables (109).  
This study was a clinical survey to describe the current practice of RSII in the 
Department of Anaesthesiology. 
3.4.2 Study population 
The study population included all the anaesthetists in the Department of 
Anaesthesiology from Wits. 
3.4.3 Study sample 
Sample size 
The sample size was determined in consultation with a biostatistician.  The department 
consists of 107 registrars, 74 specialist anaesthesiologists, 27 medical officers and 
interns, whose number vary depending on the rotation.  Questionnaires were 
administered to the accessible population.  A response rate of 60% (124) was 
considered acceptable but as this was a clinical audit a response rate of 80% (166) was 
targeted.  
Sampling method 
Sampling was done using a convenience sampling method.  This is defined as a  non-
random sampling method resulting in participants being selected because of the ease of 
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volunteering or selecting a unit because of ease of accessibility (110).  The anaesthetists 
from Wits formed a readily accessible population to sample.   
3.5.4 Inclusion and exclusion criteria 
All the anaesthetists in the Department of Anaesthesiology were invited to participate in 
the study. 
The following exclusion criteria were applied to the study: 
 anaesthetists on annual or sick leave during the study period, and 
 anaesthetists who decline to participate in the study. 
3.4.5 Data collection 
Data collection instrument 
A questionnaire including seven vignettes was used to survey current clinical practice 
(Appendix D).  Peabody et al. (111) evaluated the validity of using clinical vignettes to 
measure the quality of health care.  The authors found that vignettes provide an 
accurate and inexpensive method of measuring quality of health care comparable to the 
use of a standardised patient.  However, it is recognised that the decisions made do not 
have a direct impact on a patient’s health practically. (85)   
Koeber et al. (11) used five vignettes for the assessment of clinical practice of RSII in 
Wales (Appendix E).  These vignettes were deemed appropriate for this audit and 
permission was obtained from the authors to use and adapt where appropriate 
(Appendix F).   
The vignette describing RSII in a Caesarean section was adapted from an elective, 
healthy mother undergoing surgery, to an emergency caesarean section in a mother 
with HELLP syndrome and low platelets.  This was considered more appropriate in the 
context of South African practice.   
In addition to the aforementioned vignettes, two additional vignettes were developed to 
address chronic renal failure and the neonate which are considered important clinical 
scenarios.  These vignettes were validated by a panel of four expert anaesthesiologists 
from the Department of Anaesthesiology to ensure face and content validity. 
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The seven vignettes will include: 
1. Emergency appendectomy in a 25 year-old male, starved for over 6 hours, with 
abdominal pain and not dehydrated. 
2. Elective day case knee arthroscopy in a 40 year-old male with an endoscopically 
proven hiatus hernia and symptoms of reflux. 
3. Elective day case knee arthroscopy in a 40 year-old male with an endoscopically 
proven hiatus hernia without symptoms of reflux. 
4. Emergency Caesarean section in a mother with HELLP syndrome with a platelet 
count of 80. 
5. Emergency laparotomy for bowel obstruction in an 80 year-old female who is 
septic and dehydrated. 
6. Elective in-patient arterio-venous shunt insertion in a 40 year-old patient known 
with chronic renal failure and hypertension, with deranged urea and creatinine 
and a normal potassium.  The patient has features of autonomic dysfunction but 
has been starved for 6 hours. 
7. A 10-day old neonate with a distended abdomen, for emergency exploratory 
laparotomy. 
It was stated that for all of these clinical vignettes, the patients were not considered to 
have a difficult airway and regional anaesthesia had been refused.  
 
The following practices were assessed for each vignette: 
 preoxygenation 
 choice of induction agent 
 application and timing of CP 
 choice of NMBA 
 the use of an opioid and benzodiazepine prior to induction 
 insertion of NGT 
 use of bag mask ventilation. 
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In addition we assessed: 
 dose of induction agent used (predetermined vs. titrated) 
 technique for administration of NMBA 
 
Furthermore, the following demographic information was requested from the 
respondents: 
 age 
 gender 
 category of anaesthetist and 
 years of experience. 
Data collection method 
During the study period questionnaires were handed out at the various departmental 
meetings.  In the event that staff members could not attend these meetings, 
questionnaires were handed out to the anaesthetists in the respective departments at 
each of the hospitals. 
Anaesthetists were invited to participate in the audit and an information letter was 
made available (see Appendix G).  Agreeing to complete the questionnaire was regarded 
as implied consent.  Questionnaires were allocated a study number to monitor the 
number of questionnaires returned.  To ensure anonymity no identifying data was 
collected.  Anaesthetists placed the completed questionnaires in an unmarked envelope, 
sealed it and placed it in a sealed data collection box placed in the departmental tea 
room.  
 
3.4.6 Data analysis 
A Microsoft Excel® spreadsheet was used to capture the data.  The data was analysed 
aided by a biostatistician using Microsoft Excel® and GraphPad InStatTM.  Descriptive 
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and inferential statistics were used to analyse the data.  For categorical data, 
frequencies and percentages were used.  Furthermore, for comparison between groups, 
a chi-squared test was used.   A level of significance of 0.05 and 95% confidence 
intervals was used. 
 
3.5 Validity and Reliability 
Validity and reliability were used to ensure that the study’s conclusions were in keeping 
with the study design and results analysis.  The validity is the extent to which a 
measurement represents a true value.  Threats to validity can occur throughout the 
research process and include factors external to the study. Reliability ensures the 
consistency of the result achieved. (112) 
The validity and reliability of this study were ensured by: 
 the use of an appropriate study design and data gathering techniques 
 five of the seven vignettes were based on a previously validated questionnaire in 
the study by Koeber et al (11) 
 the seven vignettes were validated by four consultants from Wits to ensure they 
had both face and content validity 
 emphasis was placed on anonymity to ensure participants answered in 
accordance with their current practice. 
 
3.6 Summary 
The research methodology was discussed in this chapter.  In the following chapter the 
results and discussion are presented. 
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Chapter 4 
4.0  Results and discussion 
4.1  Introduction 
The sample realisation, results of the study according to the objectives and the 
discussion are presented in this chapter.   
The primary objectives of this study were to: 
 determine the proportion of anaesthetists who recognise patients at risk of 
pulmonary aspiration; 
 describe the choice of induction agent used for a RSII; 
 describe the choice of NMBA used for a RSII; 
 describe the technique used when performing a RSII. 
The secondary objectives of this study were to: 
 compare the difference in technique used between the consultant and trainee 
anaesthetists; 
 compare the difference in induction agents used between the consultant and 
trainee anaesthetists; 
 compare the difference in NMBA between the consultant and trainee 
anaesthetists; 
 describe the anaesthetists’ definition of a modified RSII. 
 
4.2  Sample realisation 
A total of 126 questionnaires were distributed in the Department of Anaesthesiology at 
academic meetings from June 2015 to February 2016.  Thus, only 60.1% of the 
Department of Anaesthesiology at the University of the Witwatersrand was surveyed 
with regard to the performance of RSII.  One questionnaire was excluded as it was 
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returned blank.  Therefore, a total of 125 questionnaires were included in the statistical 
analysis with a 99.2% response rate.    
For the purpose of fulfilling the secondary objectives of this research report, the 
designated groups were regrouped into two grades.  The first grade consisted of 
consultants (n=39).  The second grade consisted of all those considered to be trainees 
including registrars, medical officers and interns (n= 86). 
4.3  Results 
All percentages in the results will be reported according to the number of complete 
answers obtained for each question.  The percentages will be presented to one decimal 
place.  When presenting data regarding the seven vignettes in tables, the headings for 
each vignette will be represented by a corresponding number (Table 4.1).  The use of 
both a cuffed endotracheal tube and CP must be present in order for a respondent to 
fulfil the criteria for a RSII. 
Table 4.1 The seven vignettes with their corresponding number 
Vignette Number 
Appendicetomy 1 
Symptomatic hiatus hernia 2 
Asymptomatic hiatus hernia 3 
Caesarean section 4 
Bowel Obstruction 5 
Renal Failure 6 
Neonate for laparotomy 7 
 
4.3.1  Demographics 
Demographic data of the 125 respondents collected during the study is illustrated in 
Table 4.2. 
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Table 4.2 Demographics of the respondents 
Variable n (%) 
Gender 
  Female 
  Male 
n=124 
79 (63.7) 
45 (36.7) 
Grade 
  Consultant 
  Registrar 
  Medical officer/ intern 
n=125 
39 (31.2) 
61 (48.8) 
25 (20.0) 
Year of experience 
  0-5 
  6-10 
 ≥ 11 
n=125 
101 (80.8) 
9 (7.2) 
15 (12.0) 
 
Respondents were asked to indicate whether or not they had experienced a suspected 
or confirmed aspiration in the preceding year.  An incident of aspiration was reported 
by 23/125 (18.4%) respondents. 
 
4.3.2 Objective: to determine the proportion of anaesthetists who recognise 
patients at risk of pulmonary aspiration 
The respondents were asked to provide a technique for each of the seven vignettes in 
terms of securing the airway.  It was determined that the use of both an endotracheal 
tube and cricoid pressure would be considered necessary in order to fulfil the criteria 
for a RSII.  Thus, a technique in which the use of both techniques was not used, was 
considered to be a non-RSII.  The overall ability of the respondents to recognise the risk 
for pulmonary aspiration and need for a RSII across the seven vignettes was 598/824 
(72.6%) (95% CI 69.5%-75.6%). 
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Table 4.3 The technique of induction and airway management 
Technique Vignettes  
1 
n (%) 
2 
n (%) 
3 
n (%) 
4 
n (%) 
5 
n (%) 
6 
n (%) 
7 
n (%) 
RSII 97 (79.5) 93 (78.1) 38 (33.0) 113 (93.4) 114 (95.0) 89 (76.0) 54 (49.1) 
Non-RSII 25 (20.5) 26 (21.9) 77 (67.0) 8 (6.6) 6 (5.0) 28 (24.) 56 (50.9) 
n   122 119 115 121 120 117 110 
 
4.3.3  Objective: to describe the choice of induction agent used for a RSII 
The use of induction agent did not differ with regard to the seven vignettes.  Propofol 
was the most commonly employed agent with the exception of the bowel obstruction 
and neonate vignettes.  For the bowel obstruction vignette, etomidate was the agent of 
choice, with 70 (57.9%) respondents choosing to use it compared to the other agents. 
Although propofol was still used by the majority in the neonate vignette, it was only 
used by 76 (63.3%) of the respondents. Table 4.4 shows the choice of induction agent 
for each vignette. 
Table 4.4 Induction agents used for RSII in seven vignettes presented to the 
respondents 
Induction 
agent 
Vignette  
1 
n (%) 
2 
n (%) 
3 
n (%) 
4 
n (%) 
5 
n (%) 
6 
n (%) 
7 
n (%) 
  Propofol 121 (98.4) 116 (99.2) 115 (99.1) 98 (80.3) 41 (33.9) 110 (91.7) 76 (63.3) 
  Etomidate 1 (0.8) 1 (0.9) 1 (0.9) 12 (9.8) 70 (57.9) 10 (8.3) 3 (2.5) 
  Thiopentone   1 (0.8) 0 0 10 (8.2) 1 (0.8) 0 2 (1.7) 
  Other 0 0 0 2 (1.6) 9 (7.4) 0 38 (31.7) 
  n  123  117  116  122  121  120  119  
 
4.3.4  Objective: to describe the choice of NMBA used for a RSII 
The NMBA used varied between the different vignettes.  Succinylcholine was the agent 
of choice by 83 (67.5%) of respondents for the appendicectomy, 118 (96.7%) for the 
Caesarean section and 83 (68.0%) for the bowel obstruction vignettes respectively.  
Most of respondents 57(47.9%) still chose to use succinylcholine as their NMBA of 
choice for the symptomatic hiatus hernia, however, a large proportion, 36 (30.3%), 
considered the use of rocuronium for this vignette.  
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In contrast, rocuronium was the agent most commonly chosen for the asymptomatic 
hiatus hernia by 40 (34.2%) respondents.  The remainder of the respondents were 
fairly evenly split between succinylcholine 26 (22.2%), other 25 (21.4%) and none 26 
(22.2%).   
For the neonate the most commonly chosen agent was “other” by 44 (37.0%) of 
respondents with the remainder being divided between the remaining choices.  Finally, 
for the renal failure vignette the use of NMBA ranged between 8 (6.8) and 46 (39.0).  
Table 4.5 shows the choice of NMBA for each vignette. 
Table 4.5 NMBA used for RSII in seven vignettes presented to the respondents 
Neuromuscular 
blocking agent 
Vignette  
1 
n (%) 
2 
n (%) 
3 
n (%) 
4 
n (%) 
5 
n (%) 
6 
n (%) 
7 
n (%) 
   
Succinylcholine 
 
83 (67.5) 
 
57 (47.9) 
 
26 (22.2) 
 
118 (96.7) 
 
83 (68.0) 
 
43 (36.4) 
 
26 (21.9) 
  Rocuronium 28 (22.8) 36 (30.3) 40 (34.2) 3 (2.5) 34 (27.9) 21 (17.8) 25 (21.0) 
  Other 12 (9.8) 24 (20.2) 25 (21.4) 1 (0.8) 4 (4.1) 46 (39.0) 44 (37.0) 
  None 0 2 (1.7) 26 (22.2) 0 1 (0.8) 8 (6.8) 24 (20.2) 
  n  123  119  117  122  122  118  119  
 
4.3.5  Objective: to describe the technique used when performing a RSII. 
The techniques used for RSII and non-RSII 
Use of drugs and whether a non-RSII was used, is shown in Table 4.6.  The use of a RSII 
was used less frequently for the asymptomatic hiatus hernia, whilst the choice of 
induction technique for the neonate in this scenario was fairly similar for both RSII and 
non-RSII (49.1% vs 50.9%).  Of those who chose to use a RSII, the majority of 
respondents used a combination other than thiopental and succinylcholine.  For the 
symptomatic hiatus hernia, asymptomatic hiatus hernia and renal failure vignettes, no 
respondents chose to use this combination.  Although more respondents chose this 
combination for the Caesarean section, it still only comprised 8 (6.6%) out of the 
respondents.   
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Table 4.6 Induction technique used by respondents 
 
 
Rapid sequence* 
Vignette  
1 
n (%) 
2 
n (%) 
3 
n (%) 
4 
n (%) 
5 
n (%) 
6 
n (%) 
7 
n (%) 
  Thiopental 
  and  
  succinylcholine                 
1 (0.8) 0 (0.0) 0 (0.0) 8 (6.6) 1 (0.8) 0 (0.0) 1 (0.9) 
  Other drugs† 96 (78.8) 93 (79.5) 38 (34.2) 105 (86.7) 113 (93.4) 89 (75.4) 53 (47.3) 
  N 97 93 38 113 114 89 54 
Non-rapid 
sequence ‡ 
1 
n (%) 
2 
n (%) 
3 
n (%) 
4 
n (%) 
5 
n (%) 
6 
n (%) 
7 
n (%) 
  Tracheal tube 
  Without cricoid  
  Pressure 
25 (20.5) 24 (20.5) 39 (35.1) 8 (6.6) 6 (5.00) 22 (18.6) 55 (49.1) 
  No tracheal   
  Tube 
0 (0.0) 2 (1.7) 38 (34.2) 0 (0.0) 0 (0.0) 6 (5.1) 1 (0.9) 
  N 25 26 76 8 6 28 56 
*rapid sequence defined as use of tracheal tube and cricoid pressure 
†other drugs refers to any combination of induction agent and NMBA that does not include thiopental and 
succinylcholine 
‡non-rapid sequence is any technique in which a tracheal tube and/or cricoid pressure are not used  
 
 
Technique of induction administration and timing of NMBA 
 
Respondents’ preference for either a calculated or titrated dose of induction agent, as 
well as the timing of NMBA administration is shown in Table 4.7.  Of the respondents, 
62 (49.6%) indicated that they would vary the method of administering an induction 
agent, namely administering a calculated dose or titrating the dose to effect, depending 
on the clinical scenario.  Of the remaining respondents, 54 (43.2%) always administer a 
predetermined calculated dose whilst only 9 (7.2%) always titrate the induction agent 
to effect.  In terms of timing for the administration of a NMBA the most common 
response was to always wait for unconsciousness prior to NMBA administration by 51 
(40.8%) respondents.   
 
Table 4.7 Technique for administration of induction agent and timing of NMBA 
administration when performing RSII 
Induction agent (n= 125) n (%) 
  Variable depending on clinical scenario 62 (49.6) 
  Always calculated dose 54 (43.2) 
  Always titrated 9 (7.2) 
Neuromuscular blocking drug (n= 124)  
  Always after unconsciousness 51 (40.8) 
  Sometimes wait for unconsciousness 46 (36.8) 
  Always before unconsciousness 27 (21.6) 
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Non-depolarising NMBA appropriateness and technique for RSII 
 
The technique for the use of a non-depolarising NMBA when performing a RSII was 
determined for each of the agents available in the four hospitals.  Table 4.8 shows the 
agents considered appropriate for RSII and the technique used by respondents when 
using that particular agent.  It is noted that respondents could answer “yes” to both a 
fixed dose and priming technique for each of the agents.  Rocuronium is the most 
commonly used non-depolarising NMBA with 104 (84.6%) of respondents using a fixed 
dose technique and only 23 (18.6%) indicating that they would use a priming technique 
when using this agent.  Of the remaining agents the only other commonly used non-
depolarising NMBA was atracurium.  Respondents indicated that when using this agent 
a priming technique was preferable compared to a fixed dose [47 (37.6%) vs 22 
(17.6%)]. 
 
When using a fixed dose technique for rocuronium respondents quoted doses from 
0.9mg/kg to 1.2mg/kg.  In terms of the doses used for a priming technique there was a 
wide variation in the percentage of the total dose (priming dose) administered prior to 
administering the induction agent.  Doses ranged from 5% to 50% of the total calculated 
dose, with the mode dose quoted as being 10% of the total calculated dose.  One 
respondent indicated that they would give the total calculated dose of rocuronium when 
performing a priming technique prior to administering the induction agent. 
 
Table 4.8 Technique of administering non-depolarising NMBA administration 
when performing a RSII 
Agent Technique 
Priming 
n (%) 
Fixed dose 
n (%) 
Rocuronium 23 (18.6) 104 (84.6) 
Atracurium 47 (37.6) 22 (17.6) 
Cisatracurium 17 (13.6) 10 (8.0) 
Vecuronium 6 (4.8) 1 (0.8) 
Pancuronium 1 (0.8) 1 (0.8) 
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Adjuncts to RSII 
 
Table 4.9 shows the frequency with which adjuncts, namely opioid and benzodiazepine 
administration, NGT insertion and BMV were performed for each of the seven vignettes.  
Of interest is the high rate of opioid administration prior to induction for a Caesarean 
section by 85 (71.4%).  Unfortunately no data was requested in terms of agent used and 
indication for opioid use. 
 
The use of a benzodiazepine prior to the induction agent was less common than that of 
an opioid.  Use ranged between 2 (2.5%) for the Caesarean section and 18 (24.0%) for 
the asymptomatic hernia, the vignette in which it was most commonly used.   
 
The insertion of a NGT prior to induction varied depending on the clinical vignette.  For 
the bowel obstruction and neonate vignettes the majority of respondents, 105 (89.7%) 
and 94 (79.0%) respectively, reported the insertion of a NGT prior to induction.  The 
rate of insertion for the remaining scenarios varied greatly as is seen in Table 4.9.     
 
The use of BMV occurred with greater frequency in the vignettes in which a non-RSII 
was most commonly cited [asymptomatic hiatus hernia 56 (47.5%) and neonate 33 
(28.0%)].  Of the respondents who elected to use BMV for the symptomatic hernia, 
82.3% did not meet the criteria for a RSII (use of both a tracheal tube and cricoid 
pressure).  For the remaining vignettes, BMV was used by between 5 (4.1%) and 26 
(22.2%) of the respondents prior to intubation of the patient.   
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Table 4.9 The use of opioids, benzodiazepines, BMV and a NGT when performing a 
RSII 
Technique 
adjuncts 
Vignettes 
1 
n (%) 
2 
n (%) 
 
3 
n (%) 
4 
n (%) 
5 
n (%) 
6 
n (%) 
7 
n (%) 
Opioid before 
induction 
114/121 
(94.2) 
110/116 
(94.8) 
111/118 
(94.1) 
85/119 
(71.4) 
102/118 
(86.4) 
102/112 
(91.1) 
72/114 
(63.2) 
Benzodiazepine 
before 
induction 
7/84  
(8.3) 
15/77 
(19.5) 
18/75 
(24.0) 
2/81 
(2.5) 
7/76 
(9.2) 
9/68 
(13.2) 
6/66 
(9.1) 
Insertion of 
NGT 
15/123 
(12.2) 
6/114 
(5.3) 
3/117 
(2.6) 
2/119 
(1.7) 
105/117 
(89.7) 
8/113 
(7.1) 
94/119 
(79.0) 
Bag mask 
ventilation 
12/123 
(9.8) 
23/119 
(19.3) 
56/118 
(47.5) 
5/121 
(4.1) 
4/121 
(3.3) 
26/117 
(22.2) 
33/118 
(28.0) 
 
4.3.6  Secondary objective: to compare the difference in technique used between 
the consultant and trainee anaesthetists 
A Pearson chi-squared test for independence was performed to determine if there was 
any difference in terms of technique (RSII vs non-RSII) used between grades for each of 
the vignettes.  There was no statistically significant difference in technique between the 
consultants and trainees.  Table 4.10 shows the induction technique used by the 
different grades for each vignette and the associated p-value.  
 
Table 4.10 Induction technique used by the consultants and trainees 
 Vignettes  
 1 2 3 4 5 6 7 
 n (%) n (%) n (%) n (%) 
 
n (%) n (%) n (%) 
Consultants n = 37 n = 37 n=35 n=37 n=37 n=37 n=36 
Rapid 
Sequence 
26 (70.3) 26(72.2) 11 (30.6) 34 (91.9) 34 (91.9) 25 (67.6) 
 
16 (44.4) 
Non-rapid 
Sequence 
11 (29.7) 11 (30.6) 24 (66.7) 3 (8.1) 3 (8.1%) 11 (32.4) 20 (5.6) 
        
Trainees n=85 n=81 n=80 n=84 n=83 n=80 n=74 
Rapid 
Sequence 
71(81.5) 67 (83.5) 27 (33.8) 79 (94.1) 80 (96.4) 64 (80.0) 38 (51.4) 
Non-rapid 
Sequence 
14 (16.5) 14 (17.3) 53 (66.3) 5 (6.0) 3 (3.6) 16 (20.0) 36 (48.7) 
        
p-value 0.0954 0.1248 0.6386 0.6602 0.2969 0.1646 0.4966 
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4.3.7  Secondary objective: to compare the difference in induction used between 
the consultant and trainee anaesthetists 
The Pearson’s Chi-squared test for independence was used to compare the use of both 
induction agents by consultants and trainees.  For data where there were two columns 
with zeros in both cells, a Chi-squared test could not be performed, thus, a Fisher Exact 
was performed on the valid four cells.  There were no statistically significant differences 
between the consultants and trainees in any of the vignettes with regard to induction 
agent used as seen in Table 4.11. 
Table 4.11 Comparison of induction agent used by the consultants and trainees 
 Vignettes  
 1 
 
 
2 
n (%) 
3 
n (%) 
4 
n (%) 
5 
n (%) 
6 
n (%) 
7 
n (%) 
Consultant n=38 n=36 n=37 n=38 n=37 n=38 n=38 
Propofol 37 (97.4) 35 (97.2) 36 (97.3) 31 (81.6) 14 (37.8) 35 (92.1) 22 (57.9) 
Thiopentone 0 (0) (0) (0) 1 (2.6) 0 (0) 0 (0) 0 (0) 
Etomidate 1 (2.6) 1 (2.8) 1 (2.7) 5 (13.2) 21 (56.8) 3 (7.9) 0 (0) 
Other (0) (0) (0) 1 (2.6) 2 (5.4) 0 (0) 16 (42.1) 
        
Trainee n=85 n=81 n=79 n=84 n=84 n=82 n=81 
Propofol 84 (98.8) 81 (100.0) 79 (100.0) 67 (79.8) 27 (32.1) 75 (91.5) 54 (65.9) 
Thiopentone 1 (1.2) 0 (0) 0 (0) 9 (10.7) 1 (1.2) 0 (0) 2 (2.4) 
Etomidate 0 (0) 0 (0) 0 (0) 7 (8.3) 49 (58.3) 7 (8.5) 3 (3.7) 
Other 0 (0) 0 (0) 0 (0) 1 (1.2) 7 (8.3) 0(0) 22 (26.8) 
        
p-value 0.2606 - - 0.3845 0.8028 - 0.2153 
Fisher 
exact 
 0.3077 0.3190   1.0000  
 
 
 
4.3.8  Secondary objective: to compare the difference in NMBA used between the 
consultant and trainee anaesthetists 
A Pearson chi-squared for independence was used for the comparison of the NMBA 
chosen between the different grades of anaesthetist.  The results were not statistically 
significant for the seven vignettes with the exception of the appendicectomy and 
neonate (Table 4.12).  For the appendicectomy, the use of succinylcholine by trainees 
was 66/85 (77.6%) compared to 17/38 (44.7%) for consultants (p= 0.0017).  The 
neonate vignette presented a greater variation in terms of NMBA used.  Although the 
use of a NMBA in the “other” category was highest in both groups [16 (42.1%) and 28 
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(34.6%)], a larger proportion of trainees chose to omit the use of a NMBA in this 
vignette [22 (27.1%) vs 2 (5.2%)].  Furthermore, there was a higher proportion of 
consultants who chose to use succinylcholine as their agent of choice compared to the 
trainees [12 (31.6) vs 14 (17.3)].  Thus, there is a significant association with regards to 
the choice of NMBA used for the neonatal vignette and the grade of anaesthetist 
(p=0.0297). 
Table 4.12 Comparison of NMBA used by consultants and trainees 
 
4.3.9  Secondary objective: to describe the anaesthetist’s definition of a modified 
RSII 
The majority of the respondents, 97 (77.6%), considered the use of a NMBA other than 
succinylcholine to best describe the method of a modified RSII.  The preferred definition 
of a modified RSII by the remainder of respondents can be seen in Table 4.13. 
Table 4.13   Definition of a modified RSII according to respondents 
Definition of a modified rapid sequence 
induction 
n (%) 
  The use of a neuromuscular blocking agent other 
than succinylcholine 
97 (77.6) 
 The use of a neuromuscular blocking agent other 
than succinylcholine AND the use of gentle bag 
mask ventilation prior to intubation 
12 (9.6) 
  Other 11 (8.8) 
  The use of gentle bag mask ventilation prior to 
intubation 
4 (3.2) 
All of the above 1 (0.8) 
 Vignettes  
 1 
n (%) 
2 
n (%) 
 
3 
n (%) 
4 
n (%) 
5 
n (%) 
6 
n (%) 
7 
n (%) 
Consultant n=37 n=38 n=37 n=38 n=38 n=35 n=38 
Succinylcholine 17 (44.7) 17 (44.7) 8 (21.6) 36 (94.7) 25 (65.8) 10 (27.0) 12 (31.6) 
Rocuronium 13 (35.1) 10 (26.3) 10 (27.0) 1 (2.6) 10 (26.2) 6 (16.2) 8 (21.1) 
Other  7 (18.9) 11 (29.0) 6 (16.2) 1 (2.6) 3 (7.9) 19 (51.4) 16 (42.1) 
None 0 (0) 0 (0) 13 (35.2) 0 (0) 0 (0) 2 95.4) 2 (5.2) 
        
Trainee n=85 n=81 n=80 n=84 n=84 n=81 n=81 
Succinylcholine 66 (77.6) 40 (49.4) 18 (22.5) 82 (97.6) 58 (69.1) 33 (40.8) 14 (17.3) 
Rocuronium 15 (17.7) 26 (32.1) 30 (37.5) 2 (2.4) 24 (28.6) 15 (18.5) 17 (21.0) 
Other   4 (4.7) 13 (16.0) 19 (23.8) (0) 2 (2.3) 27 (33.3) 28 (34.6) 
None 0 (0) 2 (2.5) 13 (16.2) 0 (0) 0 (0) 6 (7.4) 22 (27.1) 
        
p-value 0.0015 0.3241 0.1355 0.3263 0.1608 0.3016 0.0297 
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4.4  Discussion 
To date there have been a number of surveys conducted internationally looking at the 
technique used when performing a RSII (11, 12, 14-16).  With time and medical 
advancement there has been considerable variation from the originally described 
technique in terms of both pharmacological agents used and sequence of events (10).  
There is evidence to suggest such variation may be associated with years of anaesthetic 
experience and the clinical scenario which is presented.   
Although the risk of pulmonary aspiration remains low, the morbidity and mortality 
with which it is associated, is one of the important considerations of airway associated 
complications.  The overall ability of respondents to recognise the need for a RSII, 
including a cuffed endotracheal tube and CP, was only 72.6%.  This is in contrast to the 
survey conducted in 2009 by Koerber et al. (11) where a RSII was chosen by 95% of 
participants for all vignettes with the exception of those including the hiatus hernia, 
which was influenced by the presence or absence of symptoms, 83% and 25% 
respectively.   
Respondents were asked to indicate if they had had an incidence of confirmed or 
suspected aspiration in the preceding year.  Accordingly the incidence of anaesthetist 
who experienced an episode of aspiration was determined to be 18.4%.  An incidence of 
aspiration could not be calculated as each anaesthetist performs multiple anaesthetics 
per year and the total number performed by all the respondents was not available for 
this calculation.  However, the high incidence of respondents who had experienced an 
episode of aspiration could be associated with an inability to recognise patients at risk 
for aspiration and thus perform an induction using the appropriate technique.  
Unfortunately, there is insufficient data to determine whether the cases of aspiration 
were in patients know to be at risk or whether they occurred in the absence of an 
identifiable risk. 
The results of the Wits study have been affected by 2 vignettes in particular, namely the 
asymptomatic hiatus hernia and neonate in which only 33.0% and 49.1% chose to 
perform a RSII.   There is a paucity of literature pertaining to the risk of aspiration in 
patients known with asymptomatic hiatus hernia undergoing a general anaesthetic.  A 
study done in America showed that up to 20% of asymptomatic controls had an 
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undiagnosed hiatus hernia (113).  However, with the risk of a greater residual volume 
despite appropriate fasting periods, one needs to consider whether or not a RSII would 
be more appropriate in managing these patients.  In addition it should be determined 
whether the use of appropriate pharmacological measures against aspiration alone, 
such as H2-receptor antagonists, would be sufficient in patients known with an 
asymptomatic hiatus hernia.   In our study, there was no statistically significant 
difference in the use of RSII between the consultants and trainees for the asymptomatic 
hiatus hernia (p=0.1422). This is in contrast to Koerber et al (11) who found that the 
consultant were more likely to perform a non-RSII compared to the trainees (p=0.004) 
Although 50.9% of respondents did not perform a RSII according to the definition used 
in the Wits study for the neonate, one needs to consider the current literature and 
practice when using this technique in the paediatric population.  In a survey conducted 
in the UK including members of the Association of Paediatric Anaesthetists, it was found 
that only 40-50% of anaesthetists used CP during emergency surgery on a child (68), a 
rate similar to that found in the Wits study.  The reason for this reduced incidence may 
be associated with two factors, namely the anatomical difference of the paediatric 
airway under eight years of age as well as the potential to distort the laryngeal view and 
thus potentially affect airway management.   
It has been found that lateral displacement of the oesophagus occurs in a significantly 
greater proportion of children less than eight years of age when CP is applied 
[difference in rates was 30% (95% CI 14%-46%)] (69).  Furthermore, Walker et al (70) 
found that the force necessary to occlude the airway by at least 50% in the less than 
eight years of age group, is significantly less with a mean of 10.5 N and as little as 5 N for 
those less than one year of age.  Thus, use of CP at forces typically used for adults (30 N) 
could seriously compromise the ability to efficiently manage the paediatric airway in an 
emergency (70).  However, the current recommendations for cricoid pressure in 
children is for between 22.4 N and 25.1 N (71).  With the development of a controlled 
RSII as advocated for the paediatric population, the use of CP may further fall out of 
favour.  When reviewing the rate of RSII for the neonate in the Wits study, in the 
absence of the use of CP and according to the controlled RSII technique (108), up to 
67.50% of the respondents would thus potentially have performed a RSII appropriate 
for this age group.      
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In terms of induction agent chosen, the use of propofol by both consultants and trainees 
has exceeded that of thiopentone in the Wits survey.  This is in keeping with the studies 
by Koerber et al (11)  and Sajayan et al (15) and may additionally represent the limited 
access and experience most of the respondents have with regards to Thiopentone.  For 
the bowel obstruction vignette, the use of etomidate by the majority of respondents, 
57.9 %, is also in keeping with the findings by Koerber et al (11) in 2009 where it was 
the agent most commonly used by 46% of respondents.  As they remarked, the choice of 
etomidate in this scenario is the result of recognising the potential for haemodynamic 
instability on induction in this patient population (11). 
The practice of general anaesthesia for a Caesarean section showed some variation from 
the findings of Koerber et al (11)with regards to the induction agent used for this  
vignette in the Wits survey.  Thiopentone was the most commonly used agent in the 
survey by Koerber et al (11) with 85% electing to use it .  This is in contrast to our 
survey where propofol was used by the majority, 80.3%, and only 8.2% of respondents 
chose to use thiopentone.  There is little consensus in the literature regarding the effects 
of these two different induction agents on both maternal and neonatal outcome.   
Parameters that have been assessed include haemodynamic stability on induction, 
awareness and time to arousal for the mother as well as Apgar scores for the neonate.   
However, most of the literature that is available comparing the outcomes of the 
different induction agents was published in the 1980’s and 1990’s (114-116).  
Additional studies would be necessary to determine whether or not there really is an 
impact on both maternal and neonatal outcome between these two induction agents.  
When interrogating the different aspects of the original RSII (10) a number of 
differences from the original technique were seen, with additional variation compared 
to other international surveys on RSII (11, 14, 15).  Originally, the dose of induction 
agent to be used was described as being a fixed, predetermined dose (10).  However, 
most of our respondents, 49.6%, agreed that they would use a variable approach with 
regards a fixed or titrated dose of induction agent, dependent on the clinical scenario 
with which they are presented.  Of the remaining respondents a larger proportion 
agreed that a titrated dose was more appropriate compared to a predetermined fixed 
dose (43.2% vs. 7.2%).  This shows variation to the study by Koerber et al. (11) where 
there was no difference between the use of a fixed or titrated dose.   
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The use of succinylcholine as the agent of choice when performing a RSII is in keeping 
with Morris et al. (12), Koerber et al (11) and subsequently those by Rohsbach et al. 
(16) and  Sajayan et al. (15).  However, in contrast to these studies, in this Wits study it 
was consultants and not trainees who were more likely to use high dose rocuronium, 
particularly for the appendicectomy vignette.  There is little evidence to suggest that the 
use of high dose rocuronium results in inferior conditions for securing the airway, 
especially when propofol is used as the induction agent (50, 81, 82).  The additional 
benefit of early recovery from succinylcholine should intubation fail, may become less of 
a consideration once suggamadex becomes available in the state hospitals.  However, 
the cost of suggamadex may further influence the scenarios in which it is deemed 
appropriate to use rocuronium instead of succinylcholine.  Certainly, this drug may 
change the NMBA agent most commonly used for the performance of a RSII especially in 
an emergency or difficult airway scenario. 
The technique for the use of a non-depolarising NMBA in the performance of a RSII may 
vary between a fixed dose and priming technique.  It is evident from this Wits study that 
the most commonly used non-depolarising NMBA is rocuronium in a fixed dose by 
84.6% of respondents.  Although there is literature to suggest that a priming technique 
using any of the other NMBA is acceptable, the conditions for intubation and rapidly 
securing the airway are thought to be inferior.  Furthermore, because of the variable 
onset there remains the risk of aspiration should the patient become weak with 
impaired swallowing (117, 118).  It is interesting to note that whilst the literature 
quotes a priming dose of 10% (118) and this is the most frequently quoted dose by 
54.5% of the respondents in this Wits study, there was a large variation in the priming 
dose range quoted.  This may indicate the variable time to onset of the NMBA when 
used with this technique or subsequent additional modification according to the 
respondents’ experience with the technique.   
Finally, most respondents admitted to either always waiting for signs of 
unconsciousness (40.8%) or to only sometimes waiting for signs of unconsciousness 
(36.8%) prior to giving the NMBA in a fixed dose technique.  This is in contrast to the 
original description by Stept et al. (10) but in keeping with practices described by 
Koerber et al. (11)and Sajayan et al. (15). 
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The use of an opioid prior to induction is another practice not in keeping with the 
original RSII technique.  Overall the majority of respondents, 63.2%-94.8%, admitted to 
using an opioid prior to induction of anaesthesia, a finding consistent with practice in 
the studies by Rohsbach et al. (16), Koerber et al. (11) and Sajayan et al. (15).  There is 
surprisingly little difference for use of the opioid across the seven vignettes, with 
greatest interest in the routine use of an opioid prior to induction of a general 
anaesthetic for a Caesarean section by 71.4% of respondents.   
There have been a number of studies looking at the use of an opioid to blunt the 
intubation response when performing a general anaesthetic for a Caesarean section, 
especially in the setting of preeclampsia.  Although both alfentanil and remifentanil 
have proven effective in this respect, there is concern over the need for respiratory 
support of the neonate especially if born prematurely (116, 119, 120).  Considering the 
availability of effective alternatives such as lignocaine and magnesium sulphate, for 
blunting the intubation response, particularly in the setting of preeclampsia (121), a 
study comparing the efficacy of remifentanil, alfentanil and magnesium sulphate in 
terms of attenuating the intubation response and the need to support neonatal 
ventilation post-delivery, would be of benefit.  Unfortunately, in this Wits study we 
failed to ask for specifics with regard to the opioid agent used and the indication for its 
use. 
 In this survey, although there was variation in technique across the different scenarios, 
there was a smaller variation in technique between consultants and trainees at Wits.  
This is in contrast to the study conducted by Koerber et al. (11) and Sajayan et al. (15) 
where it was found that not only the use of a RSII but also the agents used varied 
between the consultants and trainees.   This difference was particularly evident with 
regard to the more common use of propofol instead of thiopentone for induction by 
consultants only [(p≤ 0.001 and p<0.001 respectively (11, 15)].  In view of our findings, 
it stands to reason that trainees are likely to perform a technique based on that used by 
those who teach them, in this case the consultants.  There was little difference in this 
Wits study with regards to the decision to use a RSII for the seven scenarios between 
consultant and trainees (p=0.0954 to p=0.6386). 
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There is still no internationally accepted definition for a modified RSII.  The most 
commonly cited definition from our study was the use of a NMBA other than 
succinylcholine (77.6%).  This is in contrast to the survey conducted by Erhenfeld et al. 
(14) where it was the use of gentle bag mask ventilation(chosen by 77% of 
respondents) in addition to preoxygenation and CP that best represented a modified 
RSII.  
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Chapter 5 
5.0  Summary, limitations, recommendations and conclusion 
5.1  Introduction 
In this chapter a summary of the study is presented.  It will further address the 
limitations and recommendations from the study.  The overall study conclusion will be 
presented. 
5.2  Study summary 
5.2.1  Aim  
The aim of this study was to describe the current practice of anaesthetists in the 
Department of Anaesthesiology at Wits when performing a RSII using seven clinical 
vignettes. 
5.2.2  Objectives 
The primary objectives of this study were: 
 to determine the proportion of anaesthetists who recognise patients at risk of 
pulmonary aspiration; 
 to describe the choice of induction agent used for a RSII; 
 to describe the choice of NMBA used for a RSII; 
 to describe the technique used when performing a RSII. 
The secondary objectives of this study were: 
 to compare the difference in technique used between the categories of 
anaesthetist; 
 to compare the difference in induction agents used between the categories of 
anaesthetist; 
 to compare the difference in NMBA used between the categories of anaesthetist; 
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 to describe the anaesthetists’ definition of a modified RSII. 
5.2.3  Summary of the methodology 
A contextual, descriptive, prospective study was performed.  A questionnaire including 
seven validated vignettes was used to survey the current clinical practice of RSII in the 
Department of Anaesthesiology at the University of the Witwatersrand.   
The questionnaires were distributed to anaesthetists during the departmental academic 
meeting from July 2015 and February 2016.  All anaesthetists were invited to 
participate in the study.  Those who agreed to participate received an envelope 
containing an information letter and the questionnaire.  Questionnaires were placed in 
the blank envelopes provided and then into a sealed box at the meetings and 
department tea room, to maintain anonymity.  Participation in the survey was 
voluntary, thus, respondents could withdraw from the study at any time should they so 
choose. 
A response rate of 60.1% was achieved.  The findings were described and the data 
analysed using descriptive and inferential statistics. 
5.2.4  Summary of the main findings 
The overall ability to recognise the patient at risk for pulmonary aspiration 72,57% 
(95% CI 69,53%, 75,62%). 
The results showed considerable variation to the originally described technique of RSII, 
in particular with regard to the induction agent, timing of NMBA administration and 
opioid use prior to induction.  Propofol was the induction agent of choice by the 
majority of respondents with the exception of the bowel obstruction scenario where 
etomidate was preferred.  This is in contrast to the originally described use of 
thiopentone.  The majority of respondents either always or sometimes waited for signs 
of unconsciousness prior to administering the NMBA.  Finally, opioids were 
administered by the majority of respondents prior to the induction of anaesthesia. 
There was little variation in clinical practice between the different grades of 
anaesthetist, with the exception of the NMBA used for the appendicectomy and neonate 
scenarios.  For the appendicectomy consultants were less likely to use succinylcholine 
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as the NMBA of choice whilst the neonate scenario showed variation in the alternative 
to ‘other’ category between grades.   
The majority of respondents felt the term to best describe a modified RSII to be the use 
of a NMBA other than succinylcholine.     
 
5.3  Limitations 
The limitations of this study include a low response rate, particularly in the consultant 
category, which may contribute to non-responder bias particularly with regard to the 
secondary objectives.  The response rate of consultants was only 52% of consultants 
currently working in the department of anaesthesiology at Wits.  The low response rate 
amongst consultants may have occurred due to lower participation at the academic 
meeting.  Furthermore, they may have chosen not to partake in the study for fear of 
scrutiny despite guaranteeing anonymity throughout the study process. 
The low consultant response rate may have resulted in the secondary objectives being 
underpowered to find a difference between the grades of anaesthetist.  As a result, 
conclusions that are drawn from these comparisons need to be interpreted with 
caution.   
The use of a self-administered questionnaire has a number of limitations including 
failure to complete the questionnaire, an inability to obtain additional information or 
clarification from the provider as well as respondents and finally, the desire to provide 
an answer which is considered correct rather than answering according to actual 
practice. 
The questionnaire did not allow for open response particularly with regards the seven 
vignettes.  Thus, additional information regarding practice may not have been 
identified.  This is of particular relevance to the neonate scenario in light of the current 
literature and change in practice when performing a RSII in the paediatric population.  
Open responses would have allowed for the collection of richer data and thus allowed 
further insights. 
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The results of this study are specific for the Department of Anaesthesiology at Wits.  As 
a result, the conclusions that are drawn may not be generalisable to other 
anaesthesiology departments in South Africa. 
 
5.4  Recommendations 
5.4.1  Clinical practice 
The need to recognise a patient at risk for aspiration is fundamental in determining 
whether or not a RSII technique is used for a general anaesthetic.  In order to minimise 
the risk to “at risk patients”, there should be ongoing education with regard to who is at 
risk and how best to perform a RSII.  To this end the development of clinical guidelines 
regarding RSII in both the adult and paediatric patient should be considered.  Of 
importance is that there is no technique that is appropriate for all eventual scenarios, 
thus, ongoing training and professional development are crucial to minimise the 
associated morbidity and mortality associated with aspiration. 
5.4.2  Further research 
There is a still a need to provide more comprehensive data with regard to various 
aspects of performing a RSII.  Of relevance to the public setting is the potential for 
change in NMBA use when sugammadex becomes available and how this will influence 
practice.  Additional studies look at RSII practices specific to the paediatric population 
would help to clarify whether or not current practices are in keeping with both the 
literature and international practices.   
5.5  Conclusion 
Pulmonary aspiration remains one of the leading causes of significant morbidity and 
mortality during airway management.  The ability to correctly identify “at risk patients” 
is considered one the keys to preventing such risk.  However, even once “at risk 
patients” have been correctly identified, there is a lack of consensus regarding the 
performance of a RSII as there have been multiple advances in understanding and 
pharmacology since the first description of this technique.  Furthermore, the paediatric 
population itself provides additional challenges when aspiration is considered a risk 
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during airway management.  Guidelines for the performance of a RSII should be 
considered in order to facilitate decision making and the practice of this technique.  
However, it must be emphasised that clinical guidelines are only a guide to practice as 
there is no single technique that is appropriate for all scenarios. 
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Appendix C 
Information letter 
 
Date 2014 
 
Re: Variation in rapid sequence induction and intubation in 
a Department of Anaesthesiology: a clinical audit 
 
Dear colleague, 
Hello, my name is Lindsey, I am one of the registrars in our department.  For my MMED I 
will be conducting a clinical audit to look at the various practices of rapid sequence 
induction and intubation in different clinical scenarios.  Approval to conduct this study 
has been obtained from Postgraduate Committee and the Human Research Ethics 
Committee (number) of the University of the Witwatersrand.  The aim of this study is to 
ensure good clinical practice to improve both patient safety and anaesthetic teaching.   
 
I would like to invite you to take part in this audit and fill in the questionnaire that 
follows.  The questionnaire consists of 7 clinical vignettes aimed to determine current 
practice with regard to rapid sequence induction and intubation.  You will be asked to 
select the drugs and technique you deem appropriate for each of these scenarios.   The 
questionnaire is not to test your knowledge, but rather to understand the different 
practices used for rapid sequence induction and intubation during your daily practice. 
Completion of this questionnaire will take 10-15 minutes.  Participation in the study is 
voluntary. 
 
Agreeing to complete the questionnaire will be taken as implied consent, however, you 
may withdraw from participating in the study at anytime.  No identifying information 
will be requested on the questionnaire.   All completed questionnaires will remain 
confidential and anonymity ensured.  Please place the complete questionnaire in the 
unmarked envelope provided.  The sealed envelopes can be placed in the sealed box 
provided.  Participation in the study will help to benefit you both in ensuring patient 
safety and improving your ongoing anaesthetic training.  The results of the study will be 
made available to you if requested. 
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If you have any queries you can contact me on 083 383 6988 or send an email on 
Lindsey@iatrocell.com.  Further queries may be directed to the head of the ethics 
committee Prof Cleaton-Jones on 011 488 4397. 
 
Thank you for your time, 
 
Lindsey Redford 
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Appendix D 
Questionnaire  
Variation in rapid sequence induction and intubation in a 
Department of Anaesthesiology: a clinical audit 
 
Rapid sequence induction (RSI) is one of the cornerstones of anaesthetic practice. This 
survey seeks to examine the RSI techniques used by Anaesthetists in practice (not exam 
answers). 
 
 
Gender: Male  
 Female  
   
 
Your Grade? Consultant Registrar MO Intern 
(Please tick 
one) 
    
 
 
Years of experience in  0-5 6-10 11+ 
above grade    
 
What method of induction agent administration do you use during a rapid sequence 
induction and intubation? (Please tick one) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Always give a calculated dose  
Always titrate the dose against response  
Vary your method depending on clinical scenario  
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If a non- depolarising muscle relaxant is used, please indicate the agent and technique 
you prefer to use. (More than one agent may be selected) 
 
Agent Do you use a priming 
technique (what 
priming dose?) 
Do you use a fixed dose 
technique 
Rocuronium   
Atracurium   
Cisatracurium   
Vecuronium   
Pancuronium   
 
 
Do you wait for signs of unconsciousness before giving muscle relaxant during a rapid 
sequence induction? (Please tick one): 
 
 
Always  
Never  
Sometimes  
 
Have you had a suspected/ confirmed aspiration in the last year? 
 
Yes  
No  
 
Please tick which definition you consider to represent a modified rapid sequence 
induction and intubation 
 
The use of a neuromuscular blocking agent other 
than succinylcholine 
 
The use of gentle bag mask ventilation prior to 
intubation 
 
Other  
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Attached please find 7 clinical scenarios.  For each of following scenarios tick your 
preferred techniques: 
 
(All patients refuse regional techniques and there are no concerns about difficult 
intubation) 
 
 
Thank you for your time. 
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Scenario Airway Induction agent Muscle relaxant given on 
induction 
Cricoid 
Pressure 
Before induction 
agent 
NGT inserted 
prior to  
Bag mask 
ventilation 
Opioid Benzo  induction 
  
ET
T 
O
th
er
 
P
ro
p
o
fo
l 
Th
io
p
en
ta
l 
Et
o
m
id
at
e 
O
th
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Su
cc
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e
 
R
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n
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m
  
(>
 0
.9
 m
g/
kg
) 
O
th
er
 
N
o
n
e 
Ye
s 
N
o
 
Ye
s 
N
o
 
Ye
s 
N
o
 
Ye
s 
N
o
 
Ye
s 
N
o
 
1. Appendectomy, emergency, 25 year 
male, >6 hr since last meal (supper), 
has abdominal pain, not 
dehydrated. 
                                            
      
 
          
 
                          
  
  
                                          
2. Knee arthroscopy, elective day case, 
40 year male, endoscopy proven 
hiatus hernia. 
Symptoms 
of reflux 
  
 
          
 
                          
                                            
3. No 
symptoms of 
reflux 
             
 
                          
    
 
          
 
                          
                                            
4. Emergency caesarean section, for 
HELLP syndrome with platelets of 60 
    
 
          
 
                          
      
 
          
 
                          
                                              
5. Laparotomy for bowel obstruction, 
emergency, 80 yr female, 
septic and dehydrated. 
    
 
          
 
                          
      
 
          
 
                          
                                              
6. Arterial-venous fistula insertion, 
elective, 40 yr male, chronic renal 
failure, autonomic dysfunction, 
normal potassium 
    
 
          
 
                          
      
 
          
 
                          
      
 
          
 
                          
                                              
7. 10 day neonate with distended 
abdomen for emergency 
exploratory laparotomy. 
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Appendix E 
Koeber et al Questionnaire 
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Appendix F 
Letter of correspondence with Dr Koeber 
 
 
